Asymmetric alpha-Stannylation of Heterocycles and Their Subsequent Use in Cross-coupling Reactions by Zhao, Haoran
City University of New York (CUNY) 
CUNY Academic Works 
Dissertations, Theses, and Capstone Projects CUNY Graduate Center 
9-2020 
Asymmetric alpha-Stannylation of Heterocycles and Their 
Subsequent Use in Cross-coupling Reactions 
Haoran Zhao 
The Graduate Center, City University of New York 
How does access to this work benefit you? Let us know! 
More information about this work at: https://academicworks.cuny.edu/gc_etds/3988 
Discover additional works at: https://academicworks.cuny.edu 





OF HETEROCYCLES AND THEIR SUBSEQUENT USE 












A dissertation submitted to the Graduate Faculty in Chemistry in partial fulfillment of the 
requirements for the degree of Doctor of Philosophy, The City University of New York 
 
2020 























All Rights Reserved 
	   iii	  
Asymmetric alpha-Stannylation of Heterocycles 





This manuscript has been read and accepted for the Graduate Faculty in Chemistry 
in satisfaction of the dissertation requirement for the degree of Doctor of Philosophy. 
 
 
              
Date      Mark R. Biscoe 
      Chair of Examining Committee 
 
              
Date      Yolanda Small 







THE CITY UNIVERSITY OF NEW YORK 
	   iv	  
ABSTRACT 
 
Asymmetric alpha-Stannylation of Heterocycles 





Advisor: Prof. Mark R. Biscoe 
 
 Heterocyclic components exist in the majority of physiologically important compounds. 
Incorporation of these heterocyclic units modulate solubility, enhance membrane permeability, 
and control the activity of compounds in drug discovery. Therefore, the development of a reliable 
method to incorporate heterocyclic units into small molecules is attractive to chemical researchers. 
 Transition metal catalysis displays remarkable efficiency for the formation of new carbon-
carbon bonds. While the bond formation between two C(sp2) centers has been extensively studied, 
the construction of C(sp3)-C(sp2) bonds are much less common due to slow transmetallation and 
competitive β-hydride elimination. Herein, the first chapter illustrates the robustness, reliability, 
and versatility of palladium-catalyzed Stille cross-coupling reaction. Through the use of isolable, 
configurationally stable organotin nucleophiles, our lab has developed methods that enable 
unactivated secondary units to undergo cross-coupling reactions with high stereofidelity. 
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 α-Substituted oxygen-containing heterocycles are commonly present in biologically active 
molecules. Statistics shows that at least one α-substituted ether moiety appears in over 20% of the 
top 200 small-molecule pharmaceuticals. The second chapter illustrates a reliable regioselective 
method to introduce simple cyclic ethers towards the diversification of small molecules. Aryl 
halides bearing various functional groups were well tolerated independent of their electronic 
properties. It was found that cyclohexyl spectator ligands on tin selectively slows transmetallation 
of undesired units, circumventing the competitive transfer of n-butyl group from nBu3SnR reagents. 
Compared to the normally used nBu3SnR reagents, Cy3SnR organometallics benefits from lower 
toxicity and significantly higher crystallinity, which should become more appealing to synthetic 
chemists. 
 Nitrogen is the most abundant heteroatom among FDA approved pharmaceuticals. 
Particularly, α-chiral pyrrolidines are not only useful building blocks of pharmaceuticals, but also 
chiral controlling ligands in asymmetric synthesis. The third chapter reveals a general approach to 
stereospecific palladium-catalyzed cross-coupling reactions of enantioenriched nitrogen-
containing heterocycles. α-Stannylated pyrrolidine and azetidine organometallic reagents undergo 
stereospecific arylation and acylation reactions against a variety of aryl and heteroaryl 
electrophiles. High stereofidelity is achieved with predictable reagent-controlled stereochemistry 
regardless of electronic properties of electrophiles and existing stereocenters on chiral substrates. 
Late-stage functionalization could benefit from this protocol through a streamlined synthetic 
approach, avoiding the requisite time and labor consuming resolution of desired enantiomer from 
the corresponding racemic mixtures. 
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 Synthetic chemists never stop looking for better controls of atoms, molecules, and their 
interactive activities. From agriculture to medical science, the historical milestones of civilization 
have heavily depended on our ability to rationally manipulate chemical structures. It is always our 
goal to make chemistry more robust, more efficient, more selective, and more straightforward. 
In the case of a saturated carbon bearing four unique bonds, their biological activities are 
affected by the chirality. This molecular chirality was first discovered by Louis Pasteur in the mid 
19th century.1 He noticed that the sodium ammonium salt of tartaric acid crystallized into two 
different types, which appeared to be non-superimposable mirror-image. Later, he found these two 
crystals behaves drastically different in rates by microorganism metabolizing, and thereby revealed 
one enantiomer can obtain unique properties in contrast to the opposite one. 
An early case where each enantiomer of a racemate was observed to exhibit disparate 
biological activities involves Thalidomide, an infamous small molecule drug developed in the 
1950’s.2 It was initially used to combat morning sickness among pregnant women, but led to birth 
defects and other pathologies. It took 10 years and over 10,000 cases of infants with phocomelia 
before the drug stopped using. Later research showed that only the (R)-enantiomer was responsible 
for therapeutic effects, while the (S)-enantiomer caused birth defects (Figure 1.1). The man-made 





Figure 1.1. Racemate selectivity in biological process. 
 
Thus, the development of efficient and reliable methods for providing single product 
enantiomer becomes an important challenge for synthetic chemists. In the practical aspect, there 
are three common ways to obtain enantiomerically pure compound, including racemate separation, 
asymmetric induction, and stereospecific translation. All these methodologies have intrinsic pros 
and cons. Separation of racemates via self-affinity crystallization is effective, but unreliable. It is 
totally incompatible with non-crystalline materials.3 Chiral chromatography achieve racemate 
differentiation with the aid of chiral stationary phase interactions. It is extremely efficient from lab 
scale research to megatons industry work, but needs thorough method screening of optimum 
analytical conditions and deep study of solubility and stability. Moreover, exclusion of the non-
target enantiomer becomes a significant waste, causing the yield of valuable materials cut down to 
a maximum of 50%. 
 Asymmetric induction stands for absolute configuration of the target product generated 
from racemic or achiral starting materials via catalyst, enzyme, or additive control.4 It is the most 
desirable and powerful methodology because one chiral molecule in reaction system can generate 
tons of chiral products. Such economic advantages extremely benefits industry work over 
stoichiometric asymmetric synthesis. However, the enantiomeric selectivity may decrease 
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dramatically with very small electronic or steric perturbations of the substrate. Thus, substrate to 
substrate reaction condition optimizations are usually required for this methodology. 
 Stereospecific translation can be achieved through processes such as SN2 reactions, 
cylcoadditions, and transition metal catalysis. In contrast to asymmetric induction, it is a 
stoichiometric process, but benefits from extremely high efficiency and predictability. Especially 
with the aid of organometallic reagents, stereoselectivity can be independent from substrate, 
catalyst, and reaction environment.5 It provides a more general, straightforward synthetic approach 
for modern chemists to obtain enantioenriched products. 
 
1.2 Cross-coupling reactions 
 Over the past decades, transition metal-catalyzed cross-coupling reactions have played an 
essential role in synthetic organic chemistry. From laboratory to industry, these kinds of reactions 
showed great robustness, reliability, and versatility. Through the development of cross-coupling 
reactions, many important but previously impossible C-C bond-forming constructions now can be 
achieved by chemists. 
 The first report of coupling reaction was reported by Glaser in 1869, with the stoichiometric 
copper-promoted homocoupling of metallic acetylides.6 This new C(sp)-C(sp) bond-forming 
reaction lead the development of various acetylenic compounds constructions during the following 
decades. Baeyer, reported the synthesis of indigo in 1882, which was a forerunner of the modern 
combined transition-metal-catalyzed Sonogashira–heteroannulation strategies for indoles and 
related heterocycles.7 More importantly, by the usage of super-stoichiometric copper sources, 
Ullmann successfully accomplished 2-bromo- and 2-chloronitrobenzene dimerization.8 Such 
reactions occur between carbons bearing halogens, which concurrently matched the core theme of 
	  
	  4	  
organomagnesium (Grignard) and organosodium (Wurtz-Fittig) chemistry development (Figure 
1.2). 
 
Figure 1.2. Copper-mediated homocoupling process. 
  
 Cross-coupling reactions, not limited to homo-coupling process in early metal-promoted 
reactions, join two different fragments with the aid of metal catalysts. In 1955, Cadiot and 
Chodkiewicz reported the first selective cross-coupling reaction between alkynes and 
bromoalkynes (C(sp)-C(sp) coupling).9 Later in 1963, C(sp)-C(sp2) coupling with aryl or vinyl 
halides and alkynes were discovered by Castro and Stephens.10 Although poor solubility of the 
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copper salts led to batch to batch irreproducibility in yields, a potentially robust approach to solving 
the selectivity problem had shown for the first time (Figure 1.3). From then on, research on cross-
coupling reactions entered a period of systematic empirical study through which reactivity and 
selectivity were better controlled and understood. 
 
Figure 1.3. The first selective cross-coupling reactions. 
  
 Transition metal-catalyzed C-C cross-coupling reactions typically require three 
components to complete a selective transfer process: a stoichiometric main group organometallic 
nucleophile, either generated in situ or prepared separately, to prevent electrophile homocoupling; 
an electrophilic organohalide coupling partner (e.g. aryl halides and sulfonates); and a catalytic or 
stoichiometric transition metal to promote C-C bond construction process. After the innovation of 
the cross-coupling concept, its development can be roughly divided into three periods: 
identification and investigation of effective metal catalyst, extension of organometallic substrate 
scopes, and improvement of specific reaction type through ligand modification (Figure 1.4).11 
Whereas dominated by copper at the beginning, cross-coupling reaction grew dramatically with 
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the introduction of palladium and nickel catalysts in the 1960s.12 This enabled chemists to utilize 
different types of less reactive anionic organometallic reagents, overcoming the inherent 
intolerance of sensitive functional groups by organolithium and organomagnesium coupling 
methods. Continuously fine tuning of reaction conditions and supporting ligands aimed to increase 
functional group compatibility and accommodate wider substrate scope, which facilitated 
application of cross-coupling chemistry to the synthesis of biological and pharmaceutical 
molecules. 
 
Figure 1.4. Timeline of the discovery of metal catalyzed cross-coupling reactions (Ref. 11). 
 
1.3 Palladium as metal catalyst 
 Through the mid-1970s, copper, nickel, and palladium were the most useful metal catalyst 
in coupling chemistry. While copper dominated for acetylene-based substrates, and nickel solved 
selectivity problems in the Grignard reaction, palladium showed a broader tolerance of existing 
double bonds. The rapid growth of the scope of palladium-catalyzed cross-coupling reactions 
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indicated people’s interest in this highlighted metal. Today, palladium plays the most prominent 
role in transition metal-catalyzed processes. 
 Conventional palladium-catalyzed cross-coupling reactions generally undergo three 
fundamental steps, and the simplified mechanism can be defined as in Figure 1.5.13 Palladium(II) 
species are usually chosen as Pd source because of their high stability. Upon addition of ligands, 
the active Pd(0) catalyst can be generated in situ, entering the catalytic cycle. The cycle initiates 
with oxidative addition of the electrophilic aryl halide (or pseudohalide) to the low valent Pd(0) 
complex. This step normally involves a pre-coordination of Pd to the pi system of the electrophile, 
followed by an insertion event to generate the Pd(II) intermediate. Next, transmetallation of a main 
group organometallic nucleophile to the Pd(II) complex results in a new Pd(II) intermediate 
bearing both of two intended coupling partner fragments. Subsequent reductive elimination 
produces the target product with a new C-C bond formation, which simultaneously regenerates the 
active Pd(0) species, completing the catalytic cycle. 
 




 Aryl halides, including aryl bromide, iodide, and activated aryl chloride, used to be the 
“standard” electrophiles in pioneer work on palladium-catalyzed cross-coupling reactions. 
Chemists subsequently expanded the electrophile scope to other leaving groups that function in 
the same manner as the halide leaving groups, now named pseudohalides.14 These pseudohalides 
include triflates, sulfonates, hypervalent iodine, and diazonium salts, which greatly broadens the 
substrate scope for cross-coupling reactions.15 
Monodentate phosphines, bidentate phosphines, and N-heterocyclic carbenes are the most 
common ligands utilized in palladium-catalyzed cross-coupling reactions. Bidentate phosphine 
ligands tend to be particularly popular because of their stability and generality. Such bulky ligands 
also accelerate reductive elimination step by enforcing a cis orientation.16 
 Based upon the main group organometallic nucleophile employed, name reactions indicate 
chemists’ extraordinary work (Figure 1.6): Heck (no main group metal),17 Kumada (Mg),18 
Sonogashira (Cu),19 Negishi (Zn),20 Stille (Sn),21 Suzuki-Miyaura (B),22 Hiyama (Si).23 So far, 
cross-coupling reactions involving C(sp2)-C(sp2) centers are well developed with a large variety 
of substrates, catalysts, and functional groups. However, only partial success has been realized for 
C(sp2)-C(sp3) and C(sp3)-C(sp3) bond-forming reactions.  
 




1.4 C(sp3) hybridized organometallic reagents in cross-coupling reactions 
 Since sp3 hybridized carbons are most commonplace in naturally occurring molecules, 
access to catalytic cycles involving C(sp3) coupling partners has become an attractive goal. 
Protocols including primary, secondary, or tertiary alkyl systems have made it possible to induce 
desired chirality to final product.11 Thus cross-coupling reactions involving a C(sp3) hybridized 
reagent have great potential as a general synthetic tool. 
 There are two main challenges in the coupling of a C(sp3) nucleophile. First, 
transmetallation rates vary depending on the carbon unit being transferred. Alkynyl coupling 
partners typically transfer fastest, primarily because of the increased s-character in the orbital 
overlap with the d-orbital of the metal catalyst during transition state. The relatively slower rate in 
aryl and vinyl systems results from decreased s-character. Alkyl coupling groups generally transfer 
much slower, and the differentiation between each C(sp3) system is more related to steric 
properties. Basically, a primary system will process much faster than a secondary or a tertiary 
system.24 Thus, some modes of activation are commonly required to promote C(sp3) center transfer. 
 Another challenge is the kinetically competitive β-hydride elimination reaction of a Pd(II) 
complex bearing an alkyl group which contains a β-hydrogen. This undesired mechanism opens a 
chain of non-productive transformations, resulting in elimination, racemization, and isomerization 
pathways (Figure 1.7).13 Previous research indicated that utilizing strongly activated coupling 
partners, or adopting a finely tuned catalytic system could successfully overcome β-hydride 
elimination.25 Though limited by substrate scope, this paved way for chemists to pursue 
configurationally stable and optically active organometallic nucleophiles to circumvent β-hydride 




Figure 1.7. Undesired reaction pathways for organometallic reagents containing a β-hydrogen (Ref. 13). 
 
Strongly nucleophilic organometallic reagents were used in early work involving 
secondary alkyl group transmetallation. However, use of strong nucleophiles such as alkylzinc and 
alkylmagnesium reagents was limited by messy and inconsistent preparation methods, and low 
functional group compatibility. When considering the relative reactivity among main group 
organometallic nucleophiles, it is crucial to realize the inverse relationship between nucleophilicity 
and configurational stability (Figure 1.8).26 High ionic character of the carbon-metal leads to 
enhanced nucleophilicity, but lower configurational stability. As a result, strong nucleophiles 
undergo easier transmetallation, but are difficult to utilize in stereospecific couplings. In contrast, 
although alkyltin and alkylboron compounds bearing reduced nucleophilicity, the high covalency 
leads to increased configurational stability, providing more potential for undergoing a 




Figure 1.8. Inverse relationship between nucleophilicity and configurational stability for main group organometallic 
substrates (Ref. 26). 
  
 Thus far, the Suzuki-Miyaura reaction is the most widely investigated C–C cross-coupling 
procedure.22 A large variety of isolable organoboron compounds can be adopted into stereospecific 
transformation process. Moreover, organoboron reagents can tolerate a wide range of functional 
groups and are broadly commercially available, which greatly impacts their use in synthetic 
chemistry. However, there are still multiple limitations on enantiospecific Suzuki cross-couplings. 
Firstly, activating/directing groups are essential for most organoboron substrates, with yield or % 
ee decreasing in control experiments where such groups are omitted.27 This can be explained by 
the low nucleophilicity of boron among commonly used organometallic reagents, which 
necessitates activation of the alkyl group is necessary to promote transmetallation step. Secondly, 
stereospecific Suzuki cross-coupling reactions are generally unpredictable, with perturbations on 
activating/directing groups unpredictably affecting the stereochemistry of cross-coupling products. 
This severely complicates extension of an existing reaction procedure to substrates not addressed 
in the original method disclosure. Therefore, although Suzuki reactions have been widely 
investigated and applied in C(sp2)–C(sp2) cross-coupling reactions, use of alkylboron nucleophiles 




1.5 Organotin nucleophiles for asymmetric cross-coupling reactions 
 The Stille reaction has shown remarkable impact in palladium-catalyzed cross-coupling 
chemistry over the past 40 years. With the usage of isolable, configurationally stable organotin 
nucleophiles, Stille reaction has demonstrated its potential towards a general enantioselective 
cross-coupling process. 
 First observed by M. Kosugi, this type of reaction was further developed by John Stille in 
the late 1970s.28 Since organostannanes are stable to common oxidative and reductive reaction 
conditions, it is usually unnecessary to protect potetnially sensitive functional groups. The air- and 
moisture-stable nature of organotin reagents also make the cross-coupling reactions easy to handle. 
Additionally, Stille couplings are generally run under neutral conditions, bringing better functional 
group tolerance compared to Suzuki reactions. 
 As mentioned before, the transfer rate of organic groups on tin is proportional to the s-
character of C-Sn bond. Therefore, alkynyl and alkenyl/aryl moieties are readily transferred from 
a tin substrate to a palladium(II) complex. When involving a C(sp3) hybridized center, additional 
issues need to be solved. Since tin(IV) nucleophiles requires four carbon substituents, selective 
alkyl transfer requires that there be three less reactive substituents working as spectator ligands. 
Early success of transfer primary alkyl groups usually depended on tetra-substitution of the desired 
alkyl moieties, which inherently wastes three equivalents of potentially valuable molecules (Figure 
1.9).29 While activation of the desired group has been shown facilitate selectivity, slow 
transmetallation and facile β-hydride elimination remain severe drawbacks to the application of 




Figure 1.9. Early Stille cross-coupling reactions involving tetraalkylstannanes. 
 
In 1992, Vedejs group achieved selective, accelerated methyl group transfer in palladium-
catalyzed cross-coupling reaction by using methylcarbastannatrane in place of traditional 
tetramethyltin reagent (Figure 1.10).31 According to Jurkschat, the longer apical C-Sn bond 
compared to conventional tetraalkylstannanes enhances nucleophilicity of the carbastannatrane.32 
In 2013, Biscoe group published the first example of enantiospecific transfer of a completely 
unactivated secondary alkyl group in a Stille cross-coupling reaction (Figure 1.11).33 By utilizing 
a stannatrane backbone, the desired secondary alkyl substituent transferred exclusively and 
stereospecifically, with independence of its electronic and structural properties. Moreover, dummy 
ligands were no longer needed with such stannatrane backbone, which enhanced the efficiency of 
the protocol. Thus, this strategy eliminated those obstacles mentioned above, making Stille 




Figure 1.10. The first use of alkylcarbastannatrane in Stille coupling reaction by Vedejs group. 
 
Figure 1.11. The first example of completely unactivated secondary alkyl group transfer in Stille cross-coupling 
reaction by Biscoe group. 
 
1.6 Summary 
 The goal of cross-coupling reaction development is to connect two molecular fragments 
with high product yield and stereospecificity. Thus far, unsaturated systems have been thoroughly 
explored and applied to industrial, biological, and pharmaceutical production. Meanwhile, 
coupling of the more general C(sp3) center remains a challenge. Since previous investigations have 
demonstrated the robustness, high selectivity, and reliable stereospecificity of the Stille reaction, 
this dissertation focuses on attempts to expand its scope to a broader range of substrates, in order 
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Oxygen is the second most common heteroatom present in U.S. Food and Drug 
Administration (FDA) approved pharmaceuticals. By thoroughly analyzing of the 2017 FDA drug 
database, Njardarson’s group revealed 311 unique oxygen heterocycle-containing pharmaceuticals, 
which represent 15% of all approved drugs.1 More than one oxygen heterocycle appears in many 
of these drugs, and the majority (89%) of them are nonaromatic (Figure 2.1). With respect to ring 
size, it is unsurprising that 84% are five- and six-membered rings. 
 




 Alongside furanoses and pyranoses were the top two most frequently existing oxygen 
heterocycles, simplified tetrahydrofuran and tetrahydropyran ring also appeared as important 
structure constituents. Tetrahydrofuran-containing drugs are widely used in cardiovascular, 
infectious, urinary, cancer, and diabetes treatments, while tetrahydropyran-containing drugs often 
show up in immunosuppressive, oncological, and antibiotics prescriptions.2 Particularly, α-
substituted heterocycles commonly appear in the structure of biologically active modules. 
Statistics show that at least one α-substituted ether moiety appears in over 20% of the top 200 
small-molecule pharmaceuticals.3 Therefore, the development of a reliable approach for the 
incorporation of α-substituted tetrahydrofuran and tetrahydropyran units into small molecules is 
attractive to chemical researchers (Figure 2.2). 
 
Figure 2.2. Typical drugs containing α-substituted tetrahydrofuran or tetrahydropyran units. 
 
 Conventional α-substituted ether synthesis including Williamson ether synthesis, 
hydroalkoxylation, and Lewis acid-mediated nucleophilic substitution of acetals, relies on the 
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transformation of pre-existing functional groups such as heteroatoms or pi bonds.4 Although they 
can be effective methods, multiple steps are generally required. Moreover, since these α-
substituents are generally incorporated early in the synthesis, it makes late-stage incorporation of 
oxygenated heterocycles a difficult task. This results in distinct synthetic routes are required for 
each derivative of a series of the same type of compounds. In contrast, cross-coupling reactions 
undergo structural-core diversification strategy, which is a straightforward approach to obtain 
multiple analogues from similar precursors. Therefore, a selective and general applied approach, 
which can overcome the inherent low reactivity of ethers (especially saturated ethers), for coupling 
chemistry is highly desired. 
 As mentioned in Chapter 1, highly activated alkylzinc and alkylmagnesium nucleophiles 
possessed very low functional group compatibility, while less nucleophilic organotin and 
organoboron compounds have enhanced configurational stability as well as functional group 
compatibility, becoming potential organometallic reagents for transferring heteroatom-containing 
stereocenters. Over the past decade, configurationally stable, enantioenriched organoboron and 
organotin reagents had been used extensively in stereospecific palladium-catalyzed cross-coupling 
reactions. Since the intrinsically hindered secondary alkyl groups possess very slow 
transmetallation rates, specific modes of activation have generally been required, such as α-
heteroatoms, α-C(sp2) groups, ring strain, or strongly coordinating substituents (Figure 2.3).5 
Additionally, highly electron-deficient electrophiles could also accelerate the transmetallation step 
by making the palladium center more electrophilic.6 Commonly, successful transmetallation of 
secondary alkyl units from alkylboron or alkyltin substrates to Pd were achieved through specific 
combinations of these activation modes. As a result, for each specific system only substrates 
bearing requisite structural features could undergo expected reaction process. More importantly, 
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the stereochemical outcome in Suzuki cross-coupling reactions was unpredictably affected by 
minor electronic or structural perturbations of alkylboron substrates, causing potential stereocenter 
erosion.7 In contrast, cross-coupling reactions involving organotin reagents proved to maintain 
more consistently predictable stereochemical outcomes over a broad substrate scope.8 Thus, 
utilizing alkylstannane nucleophiles in stereospecific cross-coupling of heteroatom-containing 
stereocenters is a promising methodological approach. 
 
Figure 2.3. Relative transmetallation rates from organotin substrates, as well as activation strategies (Ref. 17). 
 
 From 1994 to 2018, Falck and Hoppe reported a series of selective transmetallation of 
enantioenriched alkyltin units bearing an α-oxygen substituent.9 The stereospecific Pd- and Cu-
catalyzed cross-couplings proceed with retention of configuration at the protected α-
hydroxystannane stereocenters. Whereas those stereospecific reactions proceeded smoothly with 
a large variety of open chain systems, transfer of cyclic oxygen-containing heterocycles only 
worked on epoxides (Figure 2.4). Indeed, far fewer examples of α-substituted tetrahydrofuran and 




Figure 2.4. Cross-coupling reactions of activated α-oxygen alkylstannanes. 
 
 In 2016, Walczak group published a direct stereospecific synthesis of aryl C-glycosides 
using anomeric stannanes.10 With the aid of palladium catalyst and JackiePhos ligand, 
configurationally stable anomeric stannanes undergo stereospecific cross-coupling reactions with 
aryl halides by exclusive anomeric control. Later, they prepared tetrahydrofuranosyl and 
tetrahydropyranosyl stannanes and cross-coupled them with aryl iodides (Figure 2.5). However, 
the substrate scope is extremely narrow, and it is found to be non-reproducible. By repeating their 
reported reaction conditions several times with caution, the actual yields achieved in lab are much 
lower compared to the original publication. After detailed analysis of the crude product 
components, a large quantity of n-butyl group transferred product was confirmed by GCMS and 
NMR. Thus, a reliable selective method to introduce simple cyclic ethers into small molecules 




Figure 2.5. Cross-coupling reactions of cyclic α-oxygen alkylstannanes as reported by Walczak. 
 
2.2 Optimization of reaction conditions 
 This project was aimed to achieve the α-functionalization processes of pre-existing 
tetrahydrofuran or tetrahydropyran nuclei via palladium-catalyzed Stille coupling reactions. The 
α-stannylated tetrahydrofuran or tetrahydropyran was synthesized by reacting tin lithium with 
corresponding α-chlorinated substrate. Such stannyl lithium synthesis was catalyzed by inclusion 
of a polycyclic aromatic hydrocarbon with high efficiency (Figure 2.6).11 
 
Figure 2.6. Synthesis of α-stannylated tetrahydrofuran or tetrahydropyran nuclei. 
 
Initially, tri-n-butylstannylated tetrahydropyran and ethyl 4-bromobenzoate were chosen 
as standard modules for examining the cross-coupling reaction. A finely tuned catalytic system 
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from our previous lab work was adopted to initialize reaction condition screening.12 This initial 
condition was set on a 0.02 mmol scale, using 5 mol % Pd(dba)2, 10 mol % JackiePhos, as well as 
CuCl (2 equiv) and KF (2 equiv) additives in acetonitrile. Reactions were conducted under an 
argon atmosphere and were kept stirring at 60 ºC overnight. Gas chromatography was employed 
to monitor the reaction, and dodecane was used as an internal standard to calibrate the yield of 
desired product and major byproduct. Unfortunately, only trace product could be found using these 
conditions. When reaction temperature raised to 80 ºC, the desired product yield increased to 19%, 
yet an extremely large amount (78%) of n-butyl group-transferred byproduct was revealed as the 
major product (Figure 2.7). After carefully screening of solvents and temperatures, the highest 
yield of target product reached 32% using tert-butyl alcohol at 110 ºC, which still included 41% 
of byproduct output. Further raising of temperature resulted in increased amount of byproduct, but 
did not improve the product yield. 
 




 Next, different phosphine ligands were screened based on the previous result. A series of 
biarylphosphine Buchwald ligands were tested including XPhos, BrettPhos, and Ph-SPhos, but 
only JackiePhos proved to be efficient for this transformation (Figure 2.8). This commercially 
available JackiePhos ligand was initially invented by Buchwald group in palladium-catalyzed 
amidation reactions.13 It holds multifunction that promotes various stages in the catalytic cycle. 
Due to the two bis-fluorinated aryl groups, the phosphine atom in this ligand is relatively electron 
poor. It is well known that electron-deficient palladium centers undergo slower oxidative addition, 
as well as faster transmetallation and reductive elimination.  Though aryl bromides and aryl iodides 
are viable electrophiles, aryl chlorides become less practical as a result of the electron-deficient 
palladium. The bulky biarylphosphine ligand JackiePhos can behave as a pseudo-bidentate ligand 
in a mono-ligated Pd(II) complex by rotating its electron rich lower ring inward to stabilize the 
metal charge (Figure 2.9).  Since JackiePhos is too bulky to bis-ligate active palladium catalyst, 
this lower ring stabilization also leads to exclusive cis configuration, resulting in accelerated 
reductive elimination. 
 




Figure 2.9. Unique behavior of the multifunctional JackiePhos ligand (Ref. 9). 
 
 The catalytic system also involves copper(I) chloride and potassium fluoride additives. 
Espinet has proposed that copper plays two different roles in the Stille reactions.14 First, as a known 
ligand scavenger, copper could accept ligands during steps of the catalytic cycle where an open 
coordinate site is required. For example, the palladium coordination sites can be saturated by the 
presence of excess ligand, which impedes the transmetallation mechanism. Another role of copper 
was to participate as a co-catalyst. It was assumed that organostannane transmetallated to copper 
initially, then in turn transferred to palladium. The synergic effect of copper(I) salts and fluoride 
ion was first indicated by Baldwin group, then modified by our lab in 2013.12,15 Biscoe proposed 
a more reactive organocuprate would form by a reversible transmetallation from tin to copper. The 
resulted tin chloride was then trapped by fluoride ion to form the insoluble tin fluoride irreversibly, 
pushing the equilibrium in the productive direction (Figure 2.10). Substitution of KF with CsF 





Figure 2.10. Synergic effect with copper(I) salt and fluoride ion (Ref. 8,11). 
 
 The above reaction conditions were also tested with other electrophiles. When the aryl 
halide coupling partner was switched to electron-rich 4-bromoanisole, reactivity decreased. With 
a variety of solvents and temperatures, both product and byproduct yields were less than 10% 
(Figure 2.11). Therefore, the reaction system at this point was only able to obtain desired transfer 
with low yield and in extremely narrow scope, which was far from the “generally applied, high 
efficiency” original research target. 
 




2.3 Introducing tricyclohexyltin nucleophiles into Stille reactions 
 n-Butyl group transfer from nBu3SnR nucleophiles was the major problem in the cross-
coupling reactions described above. Thus, it was essential to substitute those n-butyl groups with 
other spectator units to minimize such competitive alkyl transfer to palladium. It is well known 
that a primary group transmetallate much faster than a secondary or a tertiary group.16 Therefore, 
we proposed that use of cyclohexyl spectator ligands in place of n-butyl ligands on alkylstannane 
nucleophiles (e.g., Cy3SnR instead of nBu3SnR) would be a promising way to address this problem. 
 The corresponding tricyclohexylstannylated tetrahydropyran and tetrahydrofuran were 
synthesized via an analogous tin lithium approach to that used for tributylstannylated 
tetrahydropyran and tetrahydrofuran. Gratifyingly, when the cyclohexylstannanes were employed 
in cross-coupling reactions, sole transfer of the desired heterocycle ring was observed. Following 
slight tuning of the solvents and temperatures, excellent yields were obtained with both electron-
deficient and electron-rich aryl halides (Figure 2.12). Further investigations indicated that high 
yields maintained with catalyst loading as low as 2.5 mol % of Pd(dba)2.  The use of t-butanol as 
solvent is additionally advantageous as it has a low propensity to form peroxides and is 




Figure 2.12. Introducing cyclohexyl groups as spectator ligands. 
 
 Control experiments were conducted between tricyclohexylstannylated and tri-n-
butylstannylated oxygen-containing heterocycles over a variety of aryl halide electrophiles (Figure 
2.13). In all cases, cyclohexyl group showed predominant advantages as spectator ligands during 
the transmetallation step, resulting in exclusive transfer of the desired heterocycles. In contrast, 
tri-n-butylstannylated tetrahydropyran or tetrahydrofuran nuclei provided much lower product 




Figure 2.13. Comparison between Cy3SnR and nBu3SnR as organometallic reagents. 
 
2.4 Substrate scope 
 To evaluate the substrate scope accommodated in this cross-coupling reaction, both 
tricyclohexylstannylated tetrahydrofuran and tetrahydropyran were employed over a series of aryl 
and heteroaryl electrophiles (Figure 2.14). In general, cross-coupling products were obtained in 
moderate to good yields, with insignificant dependence on the electronic properties of aryl 
electrophiles. Electron-deficient, electron-neutral, and electron-rich aryl halides all proceeded 
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smoothly in the cross-coupling process. Various functional groups including esters, ketones, 
aldehydes, amides and nitriles were well tolerated in the catalytic cycle -- even free hydroxyl and 
secondary amine underwent successful couplings. The presence of an ortho-substituent did not 
cause any problems. Importantly, heteroaromatic electrophiles could be broadly applied in this 
strategy. 
 
Figure 2.14. Cross-coupling reactions of α-tricyclohexylstannylated tetrahydrofuran and tetrahydropyran with aryl 




2.5 Chiral nuclei synthesis 
 According to the distinct therapeutic effect between racemate drugs, asymmetric synthesis 
is always essential in modern chemistry. Among 311 unique oxygen heterocycle-containing 
pharmaceuticals analyzed by Njardarson, 75% of those oxygen heterocycles are chiral.1 Therefore, 
the construction of configurationally stable enantioenriched organometallic nucleophiles becomes 
significant to implement stereospecific translation. In this project, several strategies have been 
pursued to access enantioenriched tin substrates. The first approach was from Falck’s synthesis of 
enantioenriched α-(hydroxyalkyl)-tri-n-butylstannanes.17 This approach involved the asymmetric 
addition of in situ generated ethyl(tri-n-butylstannyl)zinc to various aldehydes in the presence of 
(S)-α,α-diphenyl-2-pyrrolidinemethanol. Upon following cyclization, tri-n-butylstannylated 
tetrahydrofuran was successfully generated in moderate yield (Figure 2.15). However, reaction 
with tricyclohexylstannane failed, with no desired product observed under various temperatures 
and solvents even with the simplest aldehyde. Such failure probably due to the intrinsic reactivity 




Figure 2.15. The addition of stannyl zinc reagent to aldehydes in the presence of chiral catalyst. 
 
 Another trial involved (-)-sparteine as ligand to create the chiral center on tin. In 1994, 
Beak described the usage of s-BuLi/(-)-sparteine in lithiation-substitution sequence to achieve 
stereospecific α-substitution of N-Boc-pyrrolidine.18 Utilizing this asymmetric lithiation procedure, 
enantioenriched tricyclohexylstannylated tetrahydrofuran might be synthesized in four steps. 
While the beginning Mitsunobu reaction and the following asymmetric stannylation went 
smoothly to generate chiral tin intermediate, this synthetic protocol failed at the deprotection step 
(Figure 2.16). A large variety of base and reducing agent were introduced in an attempt to cleave 
the ester C-O bond, but either no reaction or decomposition was observed. This phenomenon 
suggests an enormous combined shielding effect from the two ortho isopropyl groups and three 




Figure 2.16. Preparing enantioenriched tricyclohexylstannylated tetrahydrofuran via asymmetric lithiation. 
 
 While enantiomers have identical properties, diastereomers generally possess different 
physical properties, and often unique chemical reactivities. This provides a strategy by which to 
separate two epimers by recrystallization or column chromatography. Therefore, introducing a new 
chiral center to the spectator ligand on tin would be a promising methodology for preparing chiral 
organometallic substrates. Since the extremely cheap menthol, obtained from corn mint, 
peppermint, or other mints, exists as one pure stereoisomer in nature, it can be readily used as the 
secondary spectator ligand. In two steps, trimenthyltin chloride was made to furnish the 
corresponding α-stannylated tetrahydropyran, and column chromatography eluted each 
stereoisomer separately. Surprisingly, using this newly made chiral organometallic nucleophile 
under standard conditions, little desired product was produced, though a very high ratio of menthol 
group transfer was observed (Figure 2.17). This result suggests that steric effects can play a 




Figure 2.17. Using menthol group as spectator ligand on tin. 
 
2.6 Conclusion 
 In summary, we have developed a reliable regio- and chemoselective method to introduce 
simple cyclic ethers into small molecules via Pd-catalyzed Stille cross-coupling reactions. Aryl 
halides bearing various functional groups were well tolerated independent of their electronic 
properties. The use of cyclohexyl spectator ligands on tin selectively slowed transmetallation of 
undesired units, circumventing the competitive transfer of n-butyl group from nBu3SnR reagents. 
This process was demonstrated with α-tricyclohexylstannylated tetrahydropyran and 
tetrahydrofuran nucleophiles in palladium catalyzed Stille cross-coupling reactions. The air- and 
moisture-stable tin substrates will facilitate the broad use of this methodology in broad, economical, 
and operationally simple organic synthesis. Additionally, compared to the normally used nBu3SnR 
reagents, Cy3SnR organometallics benefits from lower toxicity and significantly higher 
crystallinity, which should become more attractive to synthetic chemists.19 
 Although palladium-catalyzed Stille cross-coupling reactions can be performed with high 
stereofidelity, the lack of efficient methods to synthesize chiral tin substrates is a significant 
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drawback. Since asymmetric hydrogenation has been widely applied to bioactive molecule 
synthesis, it will be an attractive approach for future studies. 
 
2.7 Experimental section 
2.7.1 General reagent/analytical information 
 BDH brand diethyl ether was purchased from VWR. EMD brand Omnisolv THF (un-
stabilized) was purchased from Fisher. These solvents were transferred to separate 20 L solvent-
delivery kegs and vigorously purged with argon for 2 h. The solvents were further purified by 
passing them under argon pressure through two packed columns of neutral alumina. Other 
anhydrous solvents (Sigma-Aldrich, SureSeal) were purged with argon prior to use. Solvents used 
for column chromatography were purchased from Fisher. Tricyclohexyltin chloride was purchased 
from Gelest, Inc. 2,3-Dihydrofuran was purchased from TCI, and 3,4-Dihydro-2H-pyran was 
purchased from Sigma-Aldrich. Reagents and solvents were used as received unless otherwise 
noted. Flash chromatography was performed using Silicycle silica gel (ultra pure grade). 
 All NMR spectra were obtained on a Bruker 300 (300 MHz for 1H, 75 MHz for 13C). All 
previously unreported compounds were additionally characterized by high resolution MS. All 1H 
NMR experiments are reported in δ units, parts per million (ppm), and were measured relative to 
the signals for residual chloroform (7.26 ppm) unless other-wise noted. The following 
abbreviations were used to express the multiplicities: s = singlet; d = doublet; t = triplet; q = quartet; 
m = multiplet; br = broad, app = apparent. All 13C NMR spectra are reported in ppm relative to 
deuterochloroform (77.23 ppm), and were obtained with 1H decoupling. High resolution MS 
analyses were performed on an Agilent 6520 Q-TOF instrument. All GC analyses were performed 
on a Shimadzu GC-2010 gas chromatograph with an FID detector using a 25 m x 0.20 mm capillary 
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column with cross-linked methyl siloxane as the stationary phase. All GC yields were calibrated 
using dodecane as an internal standard. 
 
2.7.2 General procedural information 
General procedure for cross-coupling reactions. 
On the benchtop, the electrophile (aryl bromide/iodide, 1.0 equiv), organotin (1.2 equiv), Pd(dba)2 
(2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and anhydrous KF (2.0 equiv) were added 
to an oven-dried 8 mL screw-top test tube equipped with a stirbar. The test tube was sealed with a 
screw-top septum and electrical tape. The reaction vessel was evacuated (ca. 100 mtorr) and 
backfilled with argon for 3 times. If the electrophile were liquid, it was added to the reaction vessel 
via syringe at this point. Solvent (t-Butanol, 1.0 mL) was then added via syringe. The septum was 
covered with electrical tape, and the reaction vessel was heated under 110 ºC for 12 h (unoptimized 
reaction time) using a heating block. The cooled reaction mixture was diluted with water, and 
extracted with diethyl ether (3 x 10 mL). The combined organic layers were washed with brine (10 
mL) and dried over Na2SO4. The organic layer was filtered, concentrated under reduced pressure, 
and purified by column chromatography. 
 
2.7.3 Compound characterization data 













2-Chlorotetrahydrofuran.  To an oven-dried round bottom flask under an atmosphere of argon, 
hydrogen chloride solution (2.0 M in diethyl ether) (20 mmol, 2 equiv) was added via syringe. 
Such solution was cooled to -78 ºC, followed by adding 2,3-dihydrofuran (10 mmol, 1 equiv). The 
resulting mixture was then allowed to stir at -78 ºC for 2.5 h. Solvent was removed under reduced 
pressure, and the resulting 2-chlorotetrahydrofuran (9.4 mmol, 94%) was used directly for next 
step without further purification. 
 
 
Tricyclohexyl(tetrahydrofuran-2-yl)stannane.  On the benchtop, tricyclohexylchlorotin (4 
mmol, 1 equiv), naphthalene (0.5 mmol, 12.5 mol %), and lithium (18 mmol, 4.5 equiv) were 
weighed into an oven-dried round bottom flask. After evacuated and backfilled with argon for 3 
times, tetrahydrofuran (12 mL) was added. The reaction mixture was stirred to dark green, then 
continuously stirring for another 3 hrs under room temperature. Under an argon atmosphere, 2-
chlorotetrahydrofuran (8 mmol, 2 equiv) was diluted with tetrahydrofuran (6 mL), followed by 
cooling into -78 ºC. The dark green mixture was then slowly transferred into this cooled solution. 
The resulting mixture was slowly warm to room temperature and continued stirring for overnight. 
The reaction mixture was quenched with water, extracted with diethyl ether, dried with sodium 
sulfate, and filtered. Solvent was removed under reduced pressure, and 
tricyclohexyl(tetrahydrofuran-2-yl)stannane was isolated by flash column chromatography (10% 
K2CO3/Silica gel, 1:99 diethyl ether:hexane) as a white solid (1.07 g, 61%). 1H NMR (300 MHz, 
CDCl3): δ 3.77 (m, 2H), 3.56 (m, 1H), 2.18 (m, 1H), 1.89 (m, 9H), 1.64 (m, 18H), 1.29 (m, 9H) 











2-Chlorotetrahydro-2H-pyran.  To an oven-dried round bottom flask under an atmosphere of 
argon, hydrogen chloride solution (2.0 M in diethyl ether) (20 mmol, 2 equiv) was added via 
syringe. Such solution was cooled to -78 ºC, followed by adding 3,4-dihydro-2H-pyran (10 mmol, 
1 equiv). The resulting mixture was then allowed to stir at -78 ºC for 2.5 hrs. Solvent was removed 
under reduced pressure, and the resulting 2-chlorotetrahydro-2H-pyran (9.5 mmol, 95%) was used 
directly for next step without further purification. 
 
 
Tricyclohexyl(tetrahydro-2H-pyran-2-yl)stannane.  On the benchtop, tricyclohexyl-chlorotin 
(4 mmol, 1 equiv), naphthalene (0.5 mmol, 12.5 mol %), and lithium (18 mmol, 4.5 equiv) were 
weighed into an oven-dried round bottom flask. After evacuated and backfilled with argon for 3 
times, tetrahydrofuran (12 mL) was added. The reaction mixture was stirred to dark green, then 
continuously stirring for another 3 hrs under room temperature. Then this mixture was cooled to 0 
ºC, followed by slowly addition of 2-chlorotetrahydro-2H-pyran (8 mmol, 2 equiv). The resulting 
mixture was slowly warm to room temperature and continued stirring for overnight. The reaction 











filtered. Solvent was removed under reduced pressure, and tricyclohexyl(tetrahydro-2H-pyran-2-
yl)stannane was isolated by flash column chromatography (10% K2CO3/Silica gel, 1:99 diethyl 
ether:hexane) as a white solid (1.14 g, 63%). 1H NMR (300 MHz, CDCl3): δ 3.89 (m, 2H), 3.29 
(td, J = 11.3, 2.3 Hz, 1H), 1.89 (m, 8H), 1.58 (m, 22H), 1.29 (m, 9H) ppm. 13C NMR (75 MHz, 
CDCl3): δ 76.3, 71.3, 33.3, 32.6(m), 29.6 (t, J = 26.7 Hz), 27.6, 27.5, 26.9, 26.1 ppm. 
 
 
Ethyl 4-(tetrahydrofuran-2-yl)benzoate.  The general procedure for cross-coupling reactions 
was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), ethyl 4-
bromobenzoate (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and 
KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A colorless oil (34.8 mg, 79%) was isolated by 
flash column chromatography (7:93 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 8.00 (d, 
J = 8.3 Hz, 2H), 7.39 (d, J = 8.1 Hz, 2H), 4.94 (t, J = 7.2 Hz, 1H), 4.37 (q, J = 7.1 Hz, 2H), 4.10 
(m, 1H), 3.95 (m, 1H), 2.36 (m, 1H), 2.00 (m, 2H), 1.77 (m, 1H), 1.39 (t, J = 7.1 Hz, 3H) ppm. 13C 




2-(4-Methoxyphenyl)tetrahydrofuran.  The general procedure for cross-coupling reactions was 
employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 1-bromo-4-
methoxybenzene (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and 








flash column chromatography (7:93 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 7.26 (m, 
2H), 6.87 (m, 2H), 4.83 (t, J = 7.2 Hz, 1H), 4.08 (m, 1H), 3.90 (m, 1H), 3.80 (s, 3H), 2.28 (m, 1H), 
2.00 (m, 2H), 1.79 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ 159.0, 135.5, 127.2, 113.9, 80.6, 
68.7, 55.5, 34.7, 26.3 ppm. 
 
 
1-(4-(Tetrahydrofuran-2-yl)phenyl)ethan-1-one.  The general procedure for cross-coupling 
reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 1-(4-
bromophenyl)ethan-1-one (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 
equiv), and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A colorless oil (29.3 mg, 77%) was 
isolated by flash column chromatography (15:85 ethyl acetate:hexane). 1H NMR (300 MHz, 
CDCl3): δ 7.92 (m, 2H), 7.42 (m, 2H), 4.95 (t, J = 7.2 Hz, 1H), 4.11 (m, 1H), 3.96 (m, 1H), 2.59 
(s, 3H), 2.37 (m, 1H), 2.01 (m, 2H), 1.77 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ 198.0, 149.4, 
136.3, 128.7, 125.8, 80.4, 69.1, 34.9, 26.8, 26.2 ppm. 
 
 
2-(4-(Tetrahydrofuran-2-yl)phenyl)ethan-1-ol.  The general procedure for cross-coupling 
reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 2-(4-
bromophenyl)ethan-1-ol (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 
equiv), and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A yellow oil (30 mg, 78%) was isolated 
by flash column chromatography (34:66 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 






1H), 3.84 (m, 2H), 2.85 (t, J = 6.5 Hz, 2H), 2.31 (m, 1H), 2.01 (m, 2H), 1.80 (m, 1H), 1.47 (br, 




2-(Tetrahydrofuran-2-yl)benzaldehyde.  The general procedure for cross-coupling reactions 
was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 2-iodobenzaldehyde 
(0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in 
t-butanol (1.0 mL) at 110 ºC. A colorless oil (20 mg, 57%) was isolated by flash column 
chromatography (7:93 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 10.18 (s, 1H), 7.81 
(dd, J = 7.6, 1.4 Hz, 1H), 7.73 (dd, J = 7.8, 0.5 Hz, 1H), 7.59 (td, J = 7.5, 1.3 Hz, 1H), 7.44 (td, J 
= 7.5, 1.1 Hz, 1H), 5.68 (t, J = 7.0 Hz, 1H), 4.16 (m, 1H), 3.98 (m, 1H), 2.58 (m, 1H), 1.99 (m, 
2H), 1.63 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ 193.0, 146.6, 134.2, 133.9, 132.7, 127.4, 
126.0, 77.7, 69.3, 34.7, 26.1 ppm. 
 
 
2-(Thiophen-3-yl)tetrahydrofuran.  The general procedure for cross-coupling reactions was 
employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 3-bromothiophene (0.2 
mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in t-
butanol (1.0 mL) at 110 ºC. A colorless oil (24.7 mg, 80%) was isolated by flash column 








Hz, 1H), 7.17 (m, 1H), 7.04 (dd, J = 5.0, 1.2 Hz, 1H), 4.95 (t, J = 7.0 Hz, 1H), 4.04 (m, 1H), 3.89 
(m, 1H), 2.27 (m, 1H), 1.99 (m, 2H), 1.89 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ 144.7, 
126.1, 126.0, 120.7, 77.4, 68.4, 33.6, 26.1 ppm. 
 
 
1-(4-(Tetrahydrofuran-2-yl)phenyl)-1H-pyrrole.  The general procedure for cross-coupling 
reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 1-(4-
bromophenyl)-1H-pyrrole (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 
equiv), and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A white solid (22.2 mg, 52%) was 
isolated by flash column chromatography (5:95 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): 
δ 7.37 (m, 4H), 7.08 (t, J = 2.1 Hz, 2H), 6.34 (t, J = 2.1 Hz, 2H), 4.91 (t, J = 9.0 Hz, 1H), 4.11 (q, 
J = 7.0 Hz, 1H), 3.95 (q, J = 7.0 Hz, 1H), 2.35 (m, 1H), 2.03 (m, 2H), 1.82 (m, 1H) ppm. 13C NMR 
(75 MHz, CDCl3): δ 141.1, 140.0, 127.0, 120.7, 119.6, 110.5, 80.4, 68.9, 34.8, 26.3 ppm. 
 
 
5-(Tetrahydrofuran-2-yl)-1H-indole.  The general procedure for cross-coupling reactions was 
employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 5-iodoindole (0.2 mmol), 
Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in t-butanol 
(1.0 mL) at 110 ºC. A yellow oil (30 mg, 80%) was isolated by flash column chromatography 
(15:85 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 8.17 (br, 1H), 7.63 (d, J = 0.8 Hz, 







3.96 (m, 1H), 2.35 (m, 1H), 2.05 (m, 2H), 1.93 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ 135.4, 
134.8, 127.9, 124.7, 120.5, 118.0, 111.1, 102.8, 81.7, 68.7, 35.1, 26.4 ppm. 
 
 
Methyl 3-methyl-4-(tetrahydrofuran-2-yl)benzoate.  The general procedure for cross-coupling 
reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), methyl 4-
bromo-3-methylbenzoate (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 
equiv), and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A colorless oil (33 mg, 75%) was 
isolated by flash column chromatography (7:93 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): 
δ 7.86 (m, 1H), 7.80 (m, 1H), 7.52 (d, J = 8.1 Hz, 1H), 5.08 (t, J = 7.2 Hz, 1H), 4.16 (m, 1H), 3.95 
(m, 1H), 3.90 (s, 3H), 2.40 (m, 1H), 2.34 (s, 3H), 2.01 (m, 2H), 1.63 (m, 1H) ppm. 13C NMR (75 




Ethyl 4-(tetrahydro-2H-pyran-2-yl)benzoate.  The general procedure for cross-coupling 
reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), ethyl 4-
bromobenzoate (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and 
KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A colorless oil (37 mg, 79%) was isolated by flash 
column chromatography (7:93 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 8.00 (m, 2H), 









1.38 (t, J = 7.1 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 166.8, 148.6, 129.8, 129.5, 125.8, 
79.8, 69.1, 61.0, 34.4, 26.0, 24.1, 14.5 ppm. 
 
 
2-(4-Methoxyphenyl)tetrahydro-2H-pyran.  The general procedure for cross-coupling reactions 
was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 1-bromo-4-
methoxybenzene (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and 
KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A colorless oil (22.7 mg, 59%) was isolated by 
flash column chromatography (5:95 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 7.28 (m, 
2H), 6.87 (m, 2H), 4.27 (m, 1H), 4.12 (m, 1H), 3.79 (s, 3H), 3.61 (m, 1H), 1.93 (m, 1H), 1.80 (m, 
1H), 1.62 (m, 4H) ppm. 13C NMR (75 MHz, CDCl3): δ 159.1, 135.8, 127.4, 113.9, 80.0, 69.3, 55.5, 
34.1, 26.1, 24.3 ppm. 
 
 
Phenyl(4-(tetrahydro-2H-pyran-2-yl)phenyl)methanone.  The general procedure for cross-
coupling reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 
4-bromobenzophenone (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), 
and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A colorless oil (40.5 mg, 76%) was isolated 
by flash column chromatography (15:85 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 






1.65 (m, 4H) ppm. 13C NMR (75 MHz, CDCl3): δ 196.7, 148.3, 138.0, 136.7, 132.5, 130.4, 130.2, 
128.4, 125.8, 79.8, 69.2, 34.3, 26.0, 24.1 ppm. 
 
 
2-(4-(Tetrahydro-2H-pyran-2-yl)phenyl)ethan-1-ol.  The general procedure for cross-coupling 
reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 2-(4-
bromophenyl)ethan-1-ol (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 
equiv), and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A colorless oil (29.3 mg, 71%) was 
isolated by flash column chromatography (34:66 ethyl acetate:hexane). 1H NMR (300 MHz, 
CDCl3): δ 7.30 (d, J = 8.0 Hz, 2H), 7.19 (d, J = 8.1 Hz, 2H), 4.30 (m, 1H), 4.13 (m, 1H), 3.83 (m, 
2H), 3.61 (m, 1H), 2.85 (t, J = 6.5 Hz, 2H), 1.94 (m, 1H), 1.81 (m, 1H), 1.64 (m, 4H), 1.38 (m, 
1H) ppm. 13C NMR (75 MHz, CDCl3): δ 141.7, 137.6, 129.1, 126.4, 80.1, 69.2, 63.9, 39.1, 34.1, 
26.1, 24.2 ppm. 
 
 
6-(Tetrahydro-2H-pyran-2-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one.  The general procedure for 
cross-coupling reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 
equiv), 6-bromo-2H-1,4-benzoxazin-3(4H)-one (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 
mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A pale yellow solid 
(37.8 mg, 81%) was isolated by flash column chromatography (34:66 ethyl acetate:hexane). 1H 








4.12 (m, 1H), 3.60 (m, 1H), 1.94 (m, 1H), 1.80 (m, 1H), 1.61 (m, 4H) ppm. 13C NMR (75 MHz, 
CDCl3): δ 166.1, 143.0, 138.5, 126.1, 121.9, 116.7, 113.8, 79.5, 69.2, 67.5, 34.2, 26.0, 24.1 ppm. 
 
 
2-(Thiophen-3-yl)tetrahydro-2H-pyran.  The general procedure for cross-coupling reactions 
was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 3-bromothiophene 
(0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in 
t-butanol (1.0 mL) at 110 ºC. A colorless oil (19.5 mg, 58%) was isolated by flash column 
chromatography (7:93 diethyl ether:hexane). 1H NMR (300 MHz, CDCl3): δ 7.27 (dd, J = 5.0, 3.0 
Hz, 1H), 7.19 (dt, J = 2.9, 1.0 Hz, 1H), 7.08 (dd, J = 5.0, 1.3 Hz, 1H), 4.41 (m, 1H), 4.10 (m, 1H), 
3.60 (m, 1H), 1.91 (m, 2H), 1.68 (m, 4H) ppm. 13C NMR (75 MHz, CDCl3): δ 144.7, 126.1, 125.7, 
120.7, 76.4, 69.1, 33.3, 26.1, 23.9 ppm. 
 
 
1-(4-(Tetrahydro-2H-pyran-2-yl)phenyl)-1H-pyrrole.  The general procedure for cross-
coupling reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 
1-(4-bromophenyl)-1H-pyrrole (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl 
(2.0 equiv), and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A white solid (31.8 mg, 70%) was 
isolated by flash column chromatography (5:95 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): 
δ 7.38 (m, 4H), 7.08 (t, J = 2.2 Hz, 2H), 6.34 (t, J = 2.2 Hz, 2H), 4.35 (m, 1H), 4.15 (m, 1H), 3.63 
(m, 1H), 1.96 (m, 1H), 1.86 (m, 1H), 1.65 (m, 4H) ppm. 13C NMR (75 MHz, CDCl3): δ 141.1, 









5-(Tetrahydro-2H-pyran-2-yl)-1H-indole.  The general procedure for cross-coupling reactions 
was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 5-iodoindole (0.2 
mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in t-
butanol (1.0 mL) at 110 ºC. A pale green solid (23 mg, 57%) was isolated by flash column 
chromatography (15:85 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 8.13 (br, 1H), 7.63 
(d, J = 0.8 Hz, 1H), 7.34 (d, J = 8.4 Hz, 1H), 7.21 (dd, J = 8.4, 1.6 Hz, 1H), 7.17 (t, J = 3.0 Hz, 
1H), 6.52 (m, 1H), 4.42 (m, 1H), 4.17 (m, 1H), 3.66 (m, 1H), 1.92 (m, 2H), 1.72 (m, 4H) ppm. 13C 
NMR (75 MHz, CDCl3): δ 135.5, 135.2, 128.0, 124.6, 120.8, 118.3, 111.0, 103.0, 81.2, 69.4, 34.5, 
26.3, 24.5 ppm. 
 
 
Methyl 3-methyl-4-(tetrahydro-2H-pyran-2-yl)benzoate.  The general procedure for cross-
coupling reactions was employed using tricyclohexyl(tetrahydrofuran-2-yl)stannane (1.2 equiv), 
methyl 4-bromo-3-methylbenzoate (0.2 mmol), Pd(dba)2 (2.5 mol %), JackiePhos (5 mol %), CuCl 
(2.0 equiv), and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 ºC. A pale yellow oil (27 mg, 58%) 
was isolated by flash column chromatography (7:93 ethyl acetate:hexane). 1H NMR (300 MHz, 
CDCl3): δ 7.86 (m, 1H), 7.80 (m, 1H), 7.54 (d, J = 8.1 Hz, 1H), 4.51 (dd, J = 10.9, 1.9 Hz, 1H), 









ppm. 13C NMR (75 MHz, CDCl3): δ 167.4, 146.8, 134.5, 131.5, 128.8, 127.7, 125.8, 77.1, 69.4, 
52.2, 32.9, 26.1, 24.3, 19.2 ppm. 
 





Chlorotris((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)stannane.  Magnesium turnings (132 
mmol) in dry tetrahydrofuran (30 mL) were activated by stirring with a few pieces of iodine under 
an argon atmosphere. After 5 minutes, a few drops of a solution of (-)-menthyl chloride (57 mmol) 
in tetrahydrofuran (10 mL) was added, followed by warming to 70 ºC to start the reaction. The 
remaining (-)-menthyl chloride solution was added dropwise and the reaction mixture was 
continuously heating under 70 ºC with stirring for another 4 h. Concentration of the resulting 
menthylmagnesium chloride solution was determined by titration with I2. Under an argon 
atmosphere, tin(IV) chloride (4.2 mmol) was dissolved in benzene (5 mL), followed by cooling 
into 0 ºC. The above Grignard solution was then transferred into this cooled solution dropwise. 
The resulting mixture was reflux under 85 ºC for 4 h, and continuously stirred overnight at room 






















extracted with diethyl ether. The organic layer was washed with water, dried with sodium sulfate, 
and filtered. Solvent was removed under reduced pressure, and chlorotris((1R,2S,5R)-2-isopropyl-
5-methylcyclohexyl)stannane was recrystallized in ethanol as a white solid. 1H NMR (300 MHz, 
CDCl3): δ 2.15 (m, 3H), 1.96 (m, 3H), 1.72 (m, 9H), 1.37 (m, 9H), 0.86 (m, 33H) ppm. 
 
 
Tris((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)-(tetrahydro-2H-pyran-2-yl)stannane.  On 
the benchtop, naphthalene (0.125 mmol, 12.5 mol %), and lithium (4.5 mmol, 4.5 equiv) were 
weighed into an oven-dried round bottom flask. After evacuated and backfilled with argon for 3 
times, tetrahydrofuran (2 mL) was added. The reaction mixture was stirred to dark green, then 
continuously stirring for another 1 hr under room temperature. Under an argon atmosphere, 
chlorotris((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)stannane (1 mmol, 1 equiv) was dissolved 
in tetrahydrofuran (2.5 mL), and added into the above mixture. The reaction was continuously 
stirring for another 3 hrs, followed by the addition of excess 2-chlorotetrahydro-2H-pyran (2 mmol, 
2 equiv). After stirring for overnight, the reaction mixture was quenched with water, extracted with 
diethyl ether, dried with sodium sulfate, and filtered. Solvent was removed under reduced pressure, 
and tris((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)-(tetrahydro-2H-pyran-2-yl)stannane was 
isolated by flash column chromatography (10% K2CO3/Silica gel, 1:99 diethyl ether:hexane). 1H 
NMR (300 MHz, CDCl3): δ 3.86 (m, 1H), 3.68 (m, 1H), 3.20 (m, 1H), 1.56-2.08 (m, 15H), 1.03-











Ethyl 4-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)benzoate.  The general procedure for 
cross-coupling reactions was employed using tris((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)-
(tetrahydro-2H-pyran-2-yl)stannane (1.2 equiv), ethyl 4-bromobenzoate (0.1 mmol), Pd(dba)2 (5 
mol %), JackiePhos (10 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in t-butanol (1.0 mL) at 110 
ºC. Ethyl 4-((1R,2S,5R)-2-isopropyl-5-methylcyclohexyl)benzoate (18.3 mg, 63%) was isolated 
by flash column chromatography (7:93 ethyl acetate:hexane), as well as ethyl 4-(tetrahydro-2H-
pyran-2-yl)benzoate (4.4 mg, 19%). 1H NMR (300 MHz, CDCl3): δ 7.93 (d, J = 8.4 Hz, 2H), 7.22 
(d, J = 8.3 Hz, 2H), 4.36 (q, J = 7.1 Hz, 2H), 2.50 (td, J = 11.6, 3.3 Hz, 1H), 1.78 (m, 3H), 1.49 
(m, 2H), 1.38 (t, J = 7.1 Hz, 3H), 1.11 (m, 4H), 0.90 (d, J = 6.5 Hz, 3H), 0.79 (d, J = 7.0 Hz, 3H), 
0.65 (d, J = 6.9 Hz, 3H)  ppm. 
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 Nitrogen is the most abundant heteroatom among FDA approved pharmaceuticals. By 
analyzing the database of FDA approved drugs through 2014, Njardarson found that up to 59% of 
unique small-molecule drugs included at least one nitrogen heterocycle.1 While among all drugs 
the average number of nitrogen atoms is 2.3, for drugs containing a nitrogen heterocycle, the 
number increased to 3.1 N/drug. According to ring size, five- and six-membered rings were the 
most frequently involved, and a large percentage of them were nonaromatic bearing chiral centers 
(Figure 3.1). 
 




 Among five-membered N-heterocycles, pyrrolidine emerged as the most common 
structural motif (Figure 3.2). A wide range of biological activities are shown by compounds 
containing a pyrrolidine ring.2 ABT-418 has nootropic, neuroprotective and anxiolytic effects3; 
BIRZ-227 can be used in the treatment of inflammatory disorders4; (+)-preussin displays 
antifungal activity5 (Figure 3.3). α-Chiral pyrrolidines are not only useful building blocks of 
pharmaceuticals, but also serve as chiral ligands in asymmetric synthesis.6 Therefore, 
incorporation of an α-stereocenter into pyrrolidine becomes broadly relevant to modern synthesis. 
 
Figure 3.2. Distribution of five-membered nitrogen heterocycles (Ref. 1). 
 




 While 2-arylpyrrolidines comprise essential structural motifs in biologically active 
compounds and are effective chiral controllers in asymmetric synthesis, there are few synthetic 
methods for installation of these privileged structures, and most suffer from long synthetic 
sequences, low generality, or only modest enantioselectivity.7 In 2006, Campos reported the first 
asymmetric arylation of N-Boc-pyrrolidine via Negishi coupling with high enantiomeric ratio.8 
This unprecedented work relies on a (-)-sparteine-mediated asymmetric deprotonation, followed 
by coupling with aryl bromides. Although this sequence proved to be convenient and practical, 
substrate scope was limited by the intrinsic lability of zinc reagent, especially in late stage 
functionalization process. In 2016, MacMillan developed a highly selective and general C-H 
arylation protocol through the combination of photoredox-mediated hydrogen atom transfer and 
nickel catalysis.9 This mild approach selectively functionalized α-amino sp3 C-H bonds in both 
cyclic and acyclic systems, generating racemic products in extremely broad scope (Figure 3.4). 
However, a mild, robust, and general stereospecific pathway to access 2-aryl substituted nitrogen-
containing heterocycles with different ring size has still not been realized. 
 




 Thus far, only a few examples of selective alkyl transmetallation of secondary alkyltin 
nucleophiles bearing an α-nitrogen substituent have been reported. In 2004, Chong prepared α-
sulfonamidobenzylstannanes in high enantiomeric purity. The activated benzylic carbon 
underwent a stereoinvertive transmetallation mechanism, coupling with benzoyl chloride to 
furnish expected ketones.10 In 2013, Vedejs generated substituted aziridines via Stille coupling of 
aziridinyl stannatrane with aryl or alkenyl halides. This reaction was conducted at room 
temperature with the combination effects of carbastannatrane and copper salt activation.11 Both of 
these examples, unfortunately, offered limited potential scopes because of utilizing multiple modes 
of activation. In 2013, Biscoe introduced the combined usage of enantioenriched carbastannatrane 
nucleophiles and electron deficient biarylphosphine JackiePhos ligand to overcome the 
dependence of transmetallation on remote activating groups, and successfully achieved a 
stereospecific cross-coupling reaction of completely unactivated secondary alkyl nucleophiles 
(Figure 3.5).12 However, further investigation revealed that α-carbastannatranyl pyrrolidine could 
not be generally applied in cross-coupling reactions. It was over-activated by the combining effects 
from α-nitrogen heteroatom and the presence of a carbastannatrane moiety. As a result, when less 
reactive aryl electrophiles were employed, protodestannylation would occur, leading to 
competitive decomposition process.13 Thus, other spectator ligands should be considered in place 




Figure 3.5. Prior examples of Pd-catalyzed Stille cross-coupling reactions involving the selective transfer of secondary 
nitrogen-containing nucleophiles. 
 
3.2 Reaction condition optimization 
 We initiated this project by exploring stereospecific cross-coupling reactions at α-
pyrrolidine stereocenters, which would constitute ubiquitous structural motifs in pharmaceuticals. 
Initial synthesis of α-stannylated pyrrolidine was accomplished via Beak’s lithiation approach 
using s-BuLi/(±)-sparteine and the corresponding tin chloride.14 Using this method, α-
carbastannatranyl, α-tributylstannyl, and α-tricyclohexylstannyl pyrrolidine were generated in 




Figure 3.6. Beak’s lithiation approach to α-stannylated pyrrolidine. 
  
 Standard reaction conditions from our previous carbastannatrane paper were used to 
examine the cross-coupling reaction.12 Consistent with the over-activation phenomenon mentioned 
above, reaction between α-carbastannatranyl pyrrolidine and 4-bromoanisole only furnished a 16% 
yield of arylation product. In order to reduce the reactivity and enhance the stability of the α-
stannylated pyrrolidine substrate, n-butyl groups were installed on Sn as alternative spectator 
ligand in place of carbastannatrane. However, exclusive n-butyl coupling product resulted, without 
any of the desired pyrrolidine unit transfer. Since the transmetallation rate of secondary alkyl 
groups are significantly slower than that of primary groups, n-butyl groups were then switched to 
cyclohexyl groups. This time, a comparable transmetallation rate between pyrrolidine unit and 
cyclohexyl group were observed, indicating a great potential for using cyclohexyl groups as 




Figure 3.7. Influence of tin spectator ligands on selectivity of α-pyrrolidine transfer. 
  
 After the first trial with a 1:2 product ratio of target product to cyclohexyl transfer 
byproduct, reaction conditions screened to maximize the proportion of pyrrolidine transfer. Using 
methanol under 90 ºC, pyrrolidine transmetallated predominated, yet there was still approximately 
20% of cyclohexyl transfer (Figure 3.8). A large variety of copper and palladium sources, as well 
as common additives in palladium catalyzed cross-coupling reaction were examined to minimize 
cyclohexyl group transfer, but none of them showed a significant advantage. As for coupling with 
a more electro deficient aryl electrophile, ethyl 4-bromobenzoate, the target product to byproduct 




Figure 3.8. Screening of solvents, temperatures, and additives. 
  
 We previously observed the use of α-tricyclohexylstannylated tetrahydrofuran resulted 
inexclusive transfer of the oxygen heterocycle. The major differences between the oxygen and 
nitrogen organostannane nucleophiles relate to their steric and electronic properties. It is most 
likely that the bulky N-Boc protecting group or less electronegative nitrogen atom diminished its 
transferring propensity. To address this problem, B-bromocatecholborane was used to remove the 
Boc protecting group, followed by installation of less bulky, and more electron-deficient units 
(Figure 3.9). An increased product to byproduct ratio was observed, and we determined that an 
amide was essential for the transmetallation process. While slight to moderate selectivity 
improvement was obtained with t-butylsulfonyl, acetyl, benzoyl, and other protecting groups, a 
	  
	  105	  
trifluoroacetyl protecting group was found to promote pyrrolidine transmetallation with optimal 
selectivity and excellent product yield (Figure 3.10). 
 
Figure 3.9. Nitrogen protecting group manipulation. 
 




3.3 Substrate scope 
 With the modified reaction conditions in hand, enantioenriched α-stannyl pyrrolidine 
derivatives were employed in palladium-catalyzed stereospecific cross-coupling reactions with 
various aryl electrophiles (Figure 3.11). For all reactions, pyrrolidine group transferred 
predominately, while only trace evidence of cyclohexyl transfer could be observed. Additionally, 
the transmetallation step in this catalytic cycle occurred via a stereoretentive pathway, which 
furnished α-arylated pyrrolidine in high % e.e., regardless of the electronic and structural 
properties of electrophiles. Indeed, electron-deficient, electron-neutral, electron-rich, and ortho-
substituted aryl electrophiles all underwent Stille cross-coupling reactions in moderate to good 
yield and with high enantiospecificity.  Aryl bromides, iodides, and triflates all proved to be viable 
coupling partners in this methodology. Use of heteroaryl electrophiles and electrophiles bearing 
protic functional groups were also compatible under these reaction conditions. Moreover, 
stereospecific acylation reaction was accomplished via coupling with benzoyl chloride in the 




Figure 3.11. Stereospecific cross-coupling reactions of enantioenriched (R)-N-trifluoroacetyl-2-tricyclohexylstannyl 
pyrrolidine with aryl and acyl electrophiles. 
  
 Since thioesters can be readily prepared from α-stereogenic carboxylic acids, they are 
important synthons for diastereoselective synthetic chemistry. Stereospecific cross-coupling 
reactions between enantioenriched nucleophiles and α-chiral thioesters would result in 
diastereoselectivity that is completely under reagent control. In this project, L-proline and (S)-
naproxen derived thioesters were used as acyl electrophiles to expand our substrate scope. 
Gratifyingly, excellent diastereoselectivity were achieved through coupling with both enantiomers 
of α-stannyl pyrrolidine (Figure 3.12). Therefore, influence from existing stereocenters on chiral 
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substrates proved to be negligible, and new stereocenters could be readily incorporated in a 
predictable manner. This illustrated that our reaction protocol was not only suitable for 
enantioselective process, but could also be broadly applied in diastereoselective palladium-
catalyzed Stille cross-coupling reactions. 
 
Figure 3.12. Stereospecific cross-coupling reactions of enantioenriched (R/S)-N-trifluoroacetyl-2-tricyclohexylstannyl 
pyrrolidine with thioesters. 
 
3.4 Nucleophile expansion 
 While the use of Beak’s sparteine-mediated asymmetric lithiation chemistry provided an 
efficient route to enantioenriched α-stannylated N-Boc-protected pyrrolidine compounds, it is not 
applicable to nitrogen-containing heterocycles of other ring sizes. Thus, the development of a more 
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general approach would be valuable towards expanding the universality of this cross-coupling 
protocol. 
 As the inexpensive tert-butanesulfinamide has been used extensively in asymmetric 
synthesis of diverse classes of amine-containing compounds, we proposed that enantioenriched α-
stannylated pyrrolidines and azetidines could then be prepared through a cyclization strategy using 
such Ellman’s auxiliary (Figure 3.13).15 With a multi-step synthesis, the target organotin 
nucleophiles were obtained in high % e.e. Additionally, not limited to four and five membered 
nitrogen-containing ring systems, an analogous strategy alongside appropriate precursors should 
be readily applied to the formation of larger rings. In theory, this approach should offer a universal 
access to α-stannylated, enantioenriched nitrogen-containing heterocycles. With slight 
manipulation of protecting group on nitrogen, cross-coupling reactions should proceed with 





Figure 3.13. Preparation of enantioenriched α-stannylated pyrrolidines and azetidines using Ellman auxiliary strategy. 
  
 With the aid of Ellman auxiliary, α-stannylated azetidine was prepared through this 
cyclization strategy in high enantiopurity. This time, the readily formed t-butylsulfonyl protecting 
group was enough to trigger selective transfer of the azetidine ring, probably due to the additional 
ring strain of four-member azetidine ring, which facilitates transmetallation. After slightly 
modifying the standard reaction conditions, cross-coupling with electron-deficient and electron-
neutral aryl bromides proceeded with high yield and enantioselectivity. Ester, ketone, aldehyde, 
and ortho substituents were well tolerated in this process. Through this protocol, enantioenriched 
α-aryl azetidine derivatives could be easily accessed.  This stands as the first example of a 





Figure 3.14. Stereospecific cross-coupling reactions of enantioenriched (R)-N-Bus-2-tricyclohexylstannyl azetidine. 
 
3.5 Conclusion 
 In summary, this project revealed a general approach to stereospecific palladium-catalyzed 
cross-coupling reactions of enantioenriched nitrogen-containing heterocycles. The combined use 
of biphenylphosphine ligand JackiePhos and cyclohexyl spectator ligands on organotin 
nucleophines enabled the selective transfer of a secondary alkyl unit with a minor modification of 
the protecting group on α-nitrogen atom. α-Stannylated pyrrolidine and azetidine organometallic 
reagents underwent stereospecific arylation and acylation reactions with a variety of aryl and 
heteroaryl electrophiles. High stereofidelity was achieved with predictable reagent-control 
stereochemistry regardless of electronic properties of electrophiles and existing stereocenters on 
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chiral substrates. This reaction constitutes a simple approach to introduce α-chiral amines into 
target biologically active molecules with desired chirality. 
 The unprecedented success of pyrrolidine and azetidine organometallic nucleophiles 
suggested that other systems containing α-nitrogen atom would also be feasible in stereospecific 
cross-coupling reactions. To further demonstrate the generality of this system, enantioenriched 
open-chain α-stannylated amine derivatives were prepared by other labmates in our lab.17 
Importantly, stereospecific cross-coupling reactions of non-benzylic α-stannylated secondary 
amines were accomplished for the first time (Figure 3.15). Finally, a series of potential CDK8 
inhibitors were generated through a streamlined synthetic approach using this strategy, avoiding 
the requisite time and labor consuming resolution of desired enantiomer from the corresponding 
racemic mixtures (Figure 3.16).16 
 




Figure 3.16. Preparation of new CDK8 inhibitor derivatives (2a-2d) via this strategy. 
 
3.6 Experimental section 
3.6.1 General reagent/analytical information 
BDH brand diethyl ether was purchased from VWR. EMD brand Omnisolv THF 
(unstabilized) was also purchased from VWR. These solvents were transferred to separate 20 L 
solvent-delivery kegs and vigorously purged with argon for 2 h. The solvents were further purified 
by passing them under argon pressure through two packed columns of neutral alumina. Other 
anhydrous solvents (Sigma-Aldrich, SureSeal) were purged with argon prior to use. Solvents used 
for column chromatography were purchased from VWR (BDH brand). Tricyclohexyltin chloride 
was purchased from Gelest, Inc., and N-Boc-pyrrolidine was purchased from Ark Pharm. Reagents 
and solvents were used as received unless otherwise noted. Flash chromatography was performed 
using Silicycle silica gel (ultra pure grade) and basic or neutral alumina. 
All NMR spectra were obtained on a Bruker 300 (300 MHz for 1H, 75 MHz for 13C). All 
previously unreported compounds were additionally characterized by high resolution MS. All 1H 
NMR experiments are reported in δ units, parts per million (ppm), and were measured relative to 
the signals for residual chloroform (7.26 ppm) unless otherwise noted. The following abbreviations 
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were used to express the multiplicities: s = singlet; d = doublet; t = triplet; m = multiplet; br = 
broad, app = apparent. All 13C NMR spectra are reported in ppm relative to deuterochloroform 
(77.23 ppm), and were obtained with 1H decoupling. High resolution MS analyses were performed 
on an Agilent 6520 Q-TOF instrument. All GC analyses were performed on a Shimadzu GC-2010 
gas chromatograph with an FID detector using a 25 m x 0.20 mm capillary column with cross-
linked methyl siloxane as the stationary phase, or using a 30 m x 0.32 mm chiral column (Rt®-
βDEXsm from RESTEK). All GC yields were calibrated using dodecane or tetradecane as an 
internal standard. Chiral HPLC analyses were performed using a Shimadzu Prominence HPLC 
system with binary mobile phase pumps and UV-vis detector (LC-20AB, SPD-20A) using an IA3 
(dimensions: 4.6 mm x 150 mm; particle size: 3 µm) chiral column (DAICEL CHEMICAL IND., 
LTD.), an IC3 (dimensions: 4.6 mm x 250 mm; particle size: 3 µm) chiral column (DAICEL 
CHEMICAL IND., LTD.), OD-RH (dimensions: 4.6 mm x 150 mm; particle size: 5 µm) chiral 
column (DAICEL CHEMICAL IND., LTD.), or an IA (dimensions: 4.6 mm x 150 mm; particle 
size: 5 µm) chiral column (DAICEL CHEMICAL IND., LTD.). 
 
3.6.2 General procedural information 
General procedure for cross-coupling reactions. 
On the benchtop, the electrophile (aryl bromide/triflate, thioester, or acyl chloride, 1.0 equiv), 
organotin (1.1 to 1.3 equiv), Pd(dba)2 (5 mol %), JackiePhos (10 mol % or 15 mol %), CuCl (0.5 
or 2.0 equiv), and anhydrous KF (for aryl bromide/triflate, 2.0 equiv) were added to an oven-dried 
8 mL screw-top test tube equipped with a stirbar. The test tube was sealed with a screw-top septum 
and electrical tape. The reaction vessel was evacuated (ca. 100 mtorr) and backfilled with argon 3 
times. If the electrophile were liquid, it was added to the reaction vessel via syringe at this point. 
	  
	  115	  
Solvent (CH3OH, 1,4-dioxane, or toluene, 1.0 or 0.5 mL) was then added via syringe. The septum 
was covered with electrical tape, and the reaction vessel was heated for 12 h (unoptimized reaction 
time) using a heating block. The cooled reaction mixture was transferred to a separatory funnel, 
diluted with water, and extracted with diethyl ether (3 x 10 mL). The combined organic layers 
were washed with brine (10 mL) and dried over Na2SO4. The organic layer was filtered, 
concentrated under reduced pressure, and purified by column chromatography. 
 
3.6.3 Compound characterization data 





tert-Butyl 2-(tricyclohexylstannyl)pyrrolidine-1-carboxylate.  To an oven-dried round bottom 
flask under an atmosphere of argon, tetramethylethlenediamine (TMEDA) (1.3 mmol, 1.3 equiv) 
was added via syringe.  Diethyl ether (6 mL) was then added, and the resulting solution was cooled 
to -78 ºC. To the cooled solution, s-BuLi (in cyclohexane) (1.3 mmol, 1.3 equiv) was added 
dropwisely, and the resulting mixture was then allowed to stir at -78 ºC for 30 min. Next, N-Boc-
pyrrolidine (1 mmol, 1.0 equiv) was added dropwise to the cooled solution. The resulting mixture 
was stirred at -78 ºC for 4 h. A solution of tricyclohexyltin chloride (1.5 mmol, 1.5 equiv) in 
N





















toluene (1 mL) was added. The mixture was allowed to slowly warm to rt, and stirred over-night 
at rt. The reaction mixture was poured into a separatory funnel containing a mixture of water and 
diethyl ether. The organic layer was separated, washed with brine, dried over Na2SO4, and filtered. 
Solvent was removed under reduced pressure, and tert-butyl 2-(tricyclohexylstannyl)pyrrolidine-
1-carboxylate was isolated by flash column chromatography (10% K2CO3/Silica gel, 3:97 ethyl 
acetate:hexane) as a white solid (479 mg, 88%). 1H NMR (300 MHz, CDCl3): δ 3.93 (m, 0.3H), 
3.41 (m, 1.7H), 3.17 (m, 1H), 2.17 (m, 1H), 1.88 (m, 10H), 1.55 (m, 25H), 1.29 (m, 10H) ppm. 
13C NMR (75 MHz, CDCl3): δ 153.9, 78.3, 46.2, 46.1, 33.8, 32.5, 32.2, 31.2, 30.9, 29.6, 28.9, 28.7, 
28.6, 27.4, 26.9 ppm. HRMS (ES+): Calcd (M-H)+ 540.2869; Found 540.2885. 
 
 
2,2,2-Trifluoro-1-(2-(tricyclohexylstannyl)pyrrolidin-1-yl)ethanone.  To a round-bottom flask 
under argon, tert-Butyl 2-(tricyclohexylstannyl)pyrrolidine-1-carboxylate (474 mg, 0.88 mmol) 
was added, followed by addition of DCM (2 mL). With the reaction mixture at rt, a solution of B-
bromocatecholborane (349.9 mg, 1.76 mmol, 2.0 equiv) in DCM (2 mL) was added. The mixture 
was stirred overnight at rt. The reaction was quenched by NaOH (2M aqueous, 2 mL). The mixture 
was poured into a separatory funnel containing a mixture of water and diethyl ether. The organic 
layer was separated, washed with brine, dried over Na2SO4, and filtered. Solvent was removed 
under reduced pressure to get 2-(tricyclohexylstannyl)pyrrolidine. Triethylamine (0.25 mL, 2.0 
equiv) and anhydrous DCM (3 mL) were added, and the resulting solution was cooled to 0 ºC. 
Following the dropwise addition of trifluoroacetic anhydride (0.25 mL, 2.0 equiv), the mixture 
was stirred for 10 min at 0 ºC. The mixture was then stirred overnight at rt. The resulting solution 
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was poured into a separatory funnel containing a mixture of water and diethyl ether. The organic 
layer was separated, washed with brine, dried over Na2SO4, and filtered. Solvent was removed 
under reduced pressure, and 2,2,2-trifluoro-1-(2-(tricyclohexylstannyl)pyrrolidin-1-yl)ethanone 
was isolated by flash column chroma-tography (10% K2CO3/Silica gel, 5:95 ethyl acetate:hexane) 
as a white solid (329 mg, 70%) . 1H NMR (300 MHz, CDCl3): δ 3.73 (m, 1H), 3.65 (m, 1H), 3.56 
(m, 1H), 2.23 (m, 1H), 1.79 (m, 26H), 1.30 (m, 10H) ppm. 13C NMR (75 MHz, CDCl3): δ 153.7 
(q, J = 36.0 Hz, 1C), 116.7 (q, J = 285.3 Hz), 48.3 (major), 47.1 (minor), 33.8 (major), 33.4 (minor), 
32.4 (m), 31.5 (minor), 31.2 (major), 29.4 (m), 28.9 (m), 27.3 (m) ppm. 19F NMR (282.2 MHz, 
CDCl3): δ -71.70 ppm. HRMS (ES+): Calcd (M-Na)+ 558.1986; Found 558.2004. 
 
 
(R)-tert-Butyl-2-(tricyclohexylstannyl)pyrrolidine-1-carboxylate.  To an oven-dried round 
bottom flask under an atmosphere of argon, (+)-sparteine (2.6 mmol, 1.3 equiv) was added via 
syringe. Diethyl ether (12 mL) was then added, and the resulting solution was cooled to -78 ºC. To 
the cooled solution, s-BuLi (in cyclohexane) (2.6 mmol, 1.3 equiv) was added dropwise, and the 
resulting mixture was then allowed to stir at -78 ºC for 30 min. Next, N-boc-pyrrolidine (1 mmol, 
1.0 equiv) was added dropwise to the cooled solution. The resulting mixture was stirred at -78 ºC 
for 4 h. A solution of tricyclohexyltin chloride (3 mmol, 1.5 equiv) in toluene (2 mL) was added. 
The mixture was allowed to slowly warm to rt, and stirred overnight at rt. The reaction mixture 
was poured into a separatory funnel containing a mixture of water and diethyl ether. The organic 
layer was separated, washed with brine, dried over Na2SO4, and filtered. Solvent was removed 







isolated by flash column chromatography (10% K2CO3/Silica gel, 3:97 ethyl acetate:hexane) as a 
white solid (915.2 mg, 85%). (S)-tert-butyl 2-(tricyclohexylstannyl)pyrrolidine-1-carboxylate was 
prepared through an analogous route using (–)-sparteine (452 mg, 84%). 
 
 
(R)-2,2,2-Trifluoro-1-(2-(tricyclohexylstannyl)pyrrolidin-1-yl)ethanone. To a round-bottom 
flask under argon, (R)-tert-Butyl-2-(tricyclohexylstannyl)pyrrolidine-1-carboxylate (915.2 mg, 
1.7 mmol) was added, followed by addition of DCM (4 mL). With the reaction mixture at rt, a 
solution of B-bromocatecholborane (675.9 mg, 3.4 mmol, 2.0 equiv) in DCM (4 mL) was added. 
The mixture was stirred overnight at rt. The reaction was quenched by NaOH (2M aqueous, 4 mL). 
The mixture was poured into a separatory funnel containing a mixture of water and diethyl ether. 
The organic layer was separated, washed with brine, dried over Na2SO4, and filtered. Solvent was 
removed under reduced pressure to get (R)-2-(tricyclohexylstannyl)pyrrolidine. Triethylamine 
(0.47 mL, 2.0 equiv) and anhydrous DCM (5 mL) were added, and the resulting solution was 
cooled to 0 ºC. Following the dropwise addition of trifluoroacetic anhydride (0.48 mL, 2.0 equiv), 
the mixture was stirred for 10 min at 0 ºC. The mixture was stirred overnight at rt. The resulting 
solution was poured into a separatory funnel containing a mixture of water and diethyl ether. The 
organic layer was separated, washed with brine, dried over Na2SO4, and filtered. Solvent was 
removed under reduced pressure, and (R)-2,2,2-Trifluoro-1-(2-(tricyclohexylstannyl)-pyrrolidin-
1-yl)ethanone was isolated by flash column chromatography (10% K2CO3/Silica gel, 5:95 ethyl 
acetate:hexane) as a white solid (614 mg, 68%). The ee value (97% ee) was determined by HPLC 









Phenyl-(2-(tricyclohexylstannyl)pyrrolidin-1-yl)methanone.  To a round-bottom flask under 
argon, tert-Butyl 2-(tricyclohexylstannyl)pyrrolidine-1-carboxylate (915.2 mg, 1.7 mmol) was 
added, followed by addition of DCM (1.5 mL). With the reaction mixture at rt, a solution of B-
bromocatecholborane (0.3 mmol, 2.0 equiv) in DCM (0.5 mL) was added. The mixture was stirred 
overnight at rt. The reaction was quenched by NaOH (2M aqueous, 4 mL). The mixture was poured 
into a separatory funnel containing a mixture of water and diethyl ether. The organic layer was 
separated, washed with brine, dried over Na2SO4, and filtered. Solvent was removed under reduced 
pressure to get (R)-2-(tricyclohexyl-stannyl)pyrrolidine. Triethylamine (0.06 mL, 3.0 equiv) and 
anhydrous DCM (1.5 mL) were added, and the resulting solution was cooled to 0 ºC. Following 
the dropwise addition of benzoyl chloride (0.03 mL, 2.0 equiv), the mixture was stirred for 10 min 
at 0 ºC. Then, the mixture was stirred overnight at rt. The resulting solution was poured into a 
separatory funnel containing a mixture of water and diethyl ether. The organic layer was separated, 
washed with brine, dried over Na2SO4, and filtered. The solvent was removed under reduced 
pressure. A white solid (63 mg, 78%) was isolated by flash column chromatography (10% 
K2CO3/Silica gel, 14:86 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 7.48 (m, 2H), 7.38 
(m, 3H), 3.66 (m, 1H), 3.46 (m, 1H), 3.37 (m, 1H), 2.28 (m, 1H), 1.82 (m, 26H), 1.27 (m, 10H) 
ppm. 13C NMR (75 MHz, CDCl3): δ 168.0, 137.7, 129.5, 128.3, 127.2, 50.3, 46.8, 32.6, 30.2, 29.6, 





2,2,2-Trifluoro-1-(2-(4-methoxyphenyl)pyrrolidin-1-yl)ethan-1-one.  The general procedure 
for cross-coupling reactions was employed using 2,2,2-trifluoro-1-(2-(tricyclohexylstannyl)-
pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 1-bromo-4-methoxybenzene (0.25 mmol), Pd(dba)2 (5 
mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (1.0 mL) at 90 
ºC. A white solid (51 mg, 74%) was isolated by flash column chromatography (10:90 ethyl 
acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 7.04 (m, 2H), 6.84 (m, 2H), 5.27 (m, 0.28H), 5.17 
(m, 0.72H), 3.86 (m,2H), 3.78 (s, 3H), 2.32 (m, 1H), 2.10 (m, 3H) ppm. 13C NMR (75 MHz, 
CDCl3):	  δ 158.9, 155.5 (m), 134.3 (minor), 133.3 (major), 126.7 (major), 126.1 (minor), 116.5 (q, 
J = 286.2 Hz), 114.2 (major), 114.1 (minor), 62.1 (major), 61.3 (minor), 55.4, 48.5 (minor), 47.6 
(major), 36.2 (minor), 33.6 (major), 24.3 (major), 20.2 (minor) ppm. HRMS (ES+): Calcd (M-
Na)+ 296.0874; Found 296.0901. 
 
(S)-2,2,2-Trifluoro-1-(2-(4-methoxyphenyl)pyrrolidin-1-yl)ethan-1-one.  The general 
procedure for cross-coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 1-bromo-4-methoxybenzene (0.25 
mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in 
CH3OH (1.0 mL) at 90 ºC. A white solid (45 mg, 66%) was isolated by flash column 
chromatography (10:90 ethyl acetate:hexane). The ee value (93.3% ee) was determined by chiral 





2,2,2-Trifluoro-1-(2-(4-(2-hydroxyethyl)phenyl)pyrrolidin-1-yl)ethan-1-one.  The general 
procedure for cross-coupling reactions was employed using 2,2,2-trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 2-(4-bromophenyl)ethan-1-ol (0.1 
mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in 
CH3OH (0.5 mL) at 90 ºC. A yellow liquid (20 mg, 70%) was isolated by flash column 
chromatography (30:70 to 50:50 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 7.28 (m, 
2H), 7.06 (m, 2H), 5.30 (m, 0.3H), 5.20 (m, 0.7H), 3.88 (m, 4H), 2.85 (m, 2H), 2.32 (m, 1H), 2.04 
(m, 3H), 1.45 (s, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ 155.7 (m), 140.5 (minor), 139.4 (major), 
137.9 (minor), 137.8 (major), 129.5 (major), 129.4 (minor), 125.8 (major), 125.2 (minor), 116.6 
(q, J = 286 Hz,), 63.75 (major), 63.70 (minor), 48.6 (minor), 47.7 (major), 38.98 (major), 38.90 
(minor), 36.2 (minor), 33.7 (major), 24.3 (major), 20.2 (minor) ppm. HRMS (ES+): Calcd (M-H)+ 
288.1211; Found 288.1206. 
 
(S)-2,2,2-Trifluoro-1-(2-(4-(2-hydroxyethyl)phenyl)pyrrolidin-1-yl)ethan-1-one.  The general 
procedure for cross-coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 2-(4-bromophenyl)ethan-1-ol (0.25 
mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in 
CH3OH (1.0 mL) at 90 ºC. A light yellow liquid (17 mg, 60%) was isolated by flash column 
chromatography (30:70 to 50:50 ethyl acetate:hexane). The ee value (95.6% ee) was determined 





Ethyl 4-(1-(2,2,2-trifluoroacetyl)pyrrolidin-2-yl)benzoate.  The general procedure for cross-
coupling reactions was employed using 2,2,2-trifluoro-1-(2-(tricyclohexylstannyl)pyrrolidin-1-
yl)ethan-1-one (1.3 equiv), ethyl 4-bromobenzoate (0.25 mmol), Pd(dba)2 (5 mol %), JackiePhos 
(15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (1.0 mL) at 90 ºC. A pale yellow oil 
(67.2 mg, 85%) was isolated by flash column chromatography (25:75 ethyl acetate:hexane). 1H 
NMR (300 MHz, CDCl3): δ 8.02 (m, 2H), 7.19 (m, 2H), 5.35 (m, 0.25H), 5.24 (m, 0.75H), 4.36 
(m, 2H), 3.90 (m, 2H), 2.39 (m, 1H), 2.01 (m, 3H), 1.37 (m, 3H) ppm. 13C NMR (75 MHz, CDCl3): 
δ 166.4, 155.8 (m), 147.2 (minor), 146.3 (major), 130.2 (major), 130.1 (minor), 130.0 (minor), 
129.8 (major), 125.4 (major), 125.0 (minor), 116.4 (q, J = 286.1 Hz, 1C), 62.5, 61.2 (minor), 61.1 
(major), 48.7 (minor), 47.8 (major), 36.0 (minor), 33.6 (major), 24.4 (major), 20.3 (minor), 14.4 
ppm. HRMS (ES+): Calcd (M-H)+ 316.1161; Found 316.1186. 
 
Ethyl (S)-4-(1-(2,2,2-trifluoroacetyl)pyrrolidin-2-yl)benzoate.  The general procedure for 
cross-coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), ethyl 4-bromobenzoate (0.20 
mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in 
CH3OH (1.0 mL) at 90 ºC. A pale yellow oil (47 mg, 75%) was isolated by flash column 
chromatography (25:75 ethyl acetate:hexane). The ee value (93.4% ee) was determined by chiral 





1-(2-(4-(1H-Pyrrol-1-yl)phenyl)pyrrolidin-1-yl)-2,2,2-trifluoroethan-1-one.  The general 
procedure for cross-coupling reactions was employed using 2,2,2-trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 1-(4-bromophenyl)-1H-pyrrole 
(0.25 mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) 
in CH3OH (1.0 mL) at 90 ºC. A yellow oil (66 mg, 85%) was isolated by flash column 
chromatography (10:90 to 20:80 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 7.38 (m, 
2H), 7.20 (m, 4H), 6.36 (m, 2H), 5.36 (minor, 0.27H), 5.26 (major, 0.73H), 3.95 (m, 2H), 2.42 (m, 
1H), 2.08 (m, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 155.3 (m), 140.1 (major), 139.6 (minor), 
138, 126.8 (major), 126.2 (minor), 121.0 (major), 120.7 (minor), 119.4 (major), 119.4 (minor), 
116.5 (q, J = 286.0Hz, 1C), 110.8 (minor), 110.5 (major), 62.2 (major), 61.3 (minor), 48.6 (minor), 
47.8 (major), 36.2 (minor), 33.7 (major), 24.4 (major), 20.3 (minor) ppm.  HRMS (ES+): Calcd 
(M-H)+ 309.1215; Found 309.1219. 
 
(S)-1-(2-(4-(1H-Pyrrol-1-yl)phenyl)pyrrolidin-1-yl)-2,2,2-trifluoroethan-1-one.  The general 
procedure for cross-coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 1-(4-bromophenyl)-1H-pyrrole 
(0.25 mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) 
in CH3OH (1.0 mL) at 90 ºC. A yellow oil (49 mg, 64%) was isolated by flash column 
chromatography (10:90 to 20:80 ethyl acetate:hexane). The ee value (91% ee) was determined by 





2,2,2-Trifluoro-1-(2-(o-tolyl)pyrrolidin-1-yl)ethan-1-one.  The general procedure for cross-
coupling reactions was employed using 2,2,2-trifluoro-1-(2-(tricyclohexylstannyl)pyrrolidin-1-
yl)ethan-1-one (1.3 equiv), 1-bromo-2-methylbenzene (0.25 mmol), Pd(dba)2 (5 mol %), 
JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (1.0 mL) at 90 ºC. A clear 
liquid (40 mg, 62%) was isolated by flash column chromatography (15:85 to 20:80 diethyl 
ether:hexane). 1H NMR (300 MHz, CDCl3) δ 7.18 (m, 3H), 6.94 (m, 1H), 5.45 (m, 1H), 4.03 (m, 
2H), 2.39 (m, 4H), 2.06 (m, 3H) ppm. 13C NMR (75 MHz, CDCl3) δ 155.6 (m), 140.7 (minor), 
139.5 (major), 134.4 (major), 133.3 (minor), 130.99 (major), 130.93 (minor), 127.5 (minor), 127.3 
(major), 126.4 (major), 126.3 (minor), 124.3 (minor), 123.4 (major), 116.6 (q, J = 286 Hz, 1C), 
59.9 (major), 59.3 (minor), 48.5 (m), 34.2 (minor), 32.1 (major), 24.2, 20.5 (minor), 19.5(major) 
ppm.  HRMS (ES+): Calcd (M-H)+ 258.1106; Found 258.1125. 
 
(S)-2,2,2-Trifluoro-1-(2-(o-tolyl)pyrrolidin-1-yl)ethan-1-one.  The general procedure for cross-
coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-(tricyclohexyl-stannyl)pyrrolidin-
1-yl)ethan-1-one (1.3 equiv), 1-bromo-2-methylbenzene (0.25 mmol), Pd(dba)2 (5 mol %), 
JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (1.0 mL) at 90 ºC. A clear 
liquid (29 mg, 45%) was isolated by flash column chromatography (15:85 to 20:80 diethyl 





2,2,2-Trifluoro-1-(2-(quinolin-6-yl)pyrrolidin-1-yl)ethan-1-one.  The general procedure for 
cross-coupling reactions was employed using 2,2,2-trifluoro-1-(2-(tricyclohexyl-
stannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), quinolin-6-yl trifluoromethanesulfonate (0.1 
mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in 
CH3OH (0.5 mL) at 90 ºC. A pale yellow solid (16 mg, 55%) was isolate by flash column 
chromatography (30:70 to 60:40 ethyl acetate: hexane). 1H NMR (300 MHz, CDCl3): δ 8.1 (m, 
1H), 8.11 (m, 2H), 7.45 (m, 3H), 5.50 (m, 0.24H), 5.39 (m, 0.76H), 3.97 (m, 2H), 2.45 (m, 1H), 
2.05 (m, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 150.8 (minor), 150.5 (major), 147.8, 140.4, 
139.5, 136.33 (major), 136.26 (minor), 130.42 (minor), 130.38 (major), 128.2 (major), 128.1 
(minor), 127.4 (major), 127.0 (minor), 124.1 (major), 123.4 (minor), 121.9 (minor), 121.6 (major), 
116.5 (q, J = 185.8 Hz, 1C), 62.6 (major), 61.7 (minor), 48.7 (minor), 47.9 (major), 35.9 (minor), 
33.9 (major), 24.5 (major), 20.3 (minor) ppm. 
 
(S)-2,2,2-Trifluoro-1-(2-(quinolin-6-yl)pyrrolidin-1-yl)ethanone.  The general procedure for 
cross-coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), quinolin-6-yl trifluoromethane-
sulfonate (0.1 mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 
equiv) in CH3OH (0.5 mL) at 90 ºC. A pale yellow solid (17 mg, 58%) was isolated by flash 
column chromatography (30:70 to 60:40 ethyl acetate: hexane). The ee value (98% ee) was 





4-(1-(2,2,2-Trifluoroacetyl)pyrrolidin-2-yl)benzonitrile.  The general procedure for cross-
coupling reactions was employed using 2,2,2-trifluoro-1-(2-(tricyclohexylstannyl)pyrrolidin-1-
yl)ethan-1-one (1.3 equiv), 4-bromobenzonitrile (0.25 mmol), Pd(dba)2 (5 mol %), JackiePhos (15 
mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (1.0 mL) at 90 ºC. A clear oil (46 mg, 
69%) was isolated by flash column chromatography (1:2 ethyl acetate:hexane). 1H NMR (300 
MHz, CDCl3): δ 7.46 (m, 2H), 7.24 (m, 2H), 5.34 (m, 0.2H), 5.19 (m, 0.8H), 3.91 (m, 2H), 2.40 
(m, 1H), 1.97 (m, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 156.0 (m), 147.6 (minor), 146.7 (major), 
132.8 (major), 132.7 (minor), 126.3 (major), 125.9 (major), 118.7 (major), 118.5 (minor), 116.3 
(q, J = 286.1 Hz, 1C), 111.8 (minor), 111.5 (major), 62.4 (major), 61.4 (major), 48.7 (minor), 48.0 
(major), 36.0 (major), 33.6 (major), 24.5 (major), 20.3 (minor) ppm. HRMS (ES+): Calcd (M-H)+ 
269.0902; Found 269.0900. 
 
(S)-4-(1-(2,2,2-Trifluoroacetyl)pyrrolidin-2-yl)benzonitrile.  The general procedure for cross-
coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-(tricyclohexylstannyl)pyrrolidin-
1-yl)ethan-1-one (1.3 equiv), 4-bromobenzonitrile (0.25 mmol), Pd(dba)2 (5 mol %), JackiePhos 
(15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (1.0 mL) at 90 ºC. A clear solid (36 
mg, 54%) was isolated by flash column chromatography (1:2 ethyl acetate:hexane). The ee value 





(2-(1H-Indol-5-yl)pyrrolidin-1-yl)-2,2,2-trifluoroethan-1-one.  The general procedure for 
cross-coupling reactions was employed using 2,2,2-trifluoro-1-(2-(tricyclohexyl-
stannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 5-iodo-1H-indole (0.1 mmol), Pd(dba)2 (5 mol %), 
JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (0.5 mL) at 90 ºC. A pale 
red solid (14.1 mg, 50%) was isolated by flash column chromatography (25:75 ethyl 
acetate:hexane).  1H NMR (300 MHz, CDCl3): δ 8.15 (b, 1H), 7.36 (m, 2 H), 7.20 (m, 1H), 6.96 
(m, 1H), 6.51 (m, 1H), 5.37 (m, 1H), 3.93 (m, 2H), 2.34 (m, 1H), 2.03 (m, 3H) ppm. 13C NMR (75 
MHz, CDCl3): δ 156.0 (m), 135.3 (major), 135.1 (minor), 133.9 (minor), 132.8 (major), 128.1 
(major), 127.9 (minor), 125.2 (minor), 125.0 (major), 120.0 (major), 119.3 (minor), 117.3(major), 
116.9 (minor), 111.5 (major), 114.4 (minor), 102.8, 63.1 (major), 62.2 (minor, m), 48.2 (m), 36.6, 
34.2, 24.29, 20.2 ppm. HRMS (ES+): Calcd (M-H)+ 283.1058; Found 283.1059. 
 
(S)-1-(2-(1H-Indol-5-yl)pyrrolidin-1-yl)-2,2,2-trifluoroethan-1-one.  The general procedure for 
cross-coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 5-iodo-1H-indole (0.25 mmol), 
Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (1.0 
mL) at 90 ºC. A pale red solid (37 mg, 53%) was isolated by flash column chromatography (25:75 






2,2,2-Trifluoro-1-(2-(thiophen-3-yl)pyrrolidin-1-yl)ethan-1-one.  The general procedure for 
cross-coupling reactions was employed using 2,2,2-trifluoro-1-(2-(tricyclohexyl-
stannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 3-bromothiophene (0.25 mmol), Pd(dba)2 (5 
mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (1.0 mL) at 90 
ºC. A clear oil (32 mg, 51%) was isolated by flash column chromatography (20:80 to 30:70 diethyl 
ether: hexane). 1H NMR (300 MHz, CDCl3): δ 7.29 (m, 1H), 6.93 (m, 2H), 5.36 (m, 1H), 3.82 (m, 
2H), 2.12 (m, 4H) ppm. 13C NMR (75 MHz, CDCl3): δ 155.7, 143.1 (minor), 141.8 (major), 126.9 
(minor), 126.5 (major), 125.8 (major), 125.2 (minor), 120.9 (major), 120.3 (minor), 116.5 (q, J = 
286.1Hz, 1C), 58.7, 47.8 (minor), 46.9 (major), 36.5 (minor), 32.4 (major), 24.4 (major), 20.6 
(minor) ppm.  HRMS (ES+): Calcd (M-H)+ 250.0513; Found 250.0515. 
 
(S)-2,2,2-Trifluoro-1-(2-(thiophen-3-yl)pyrrolidin-1-yl)ethan-1-one.  The general procedure 
for cross-coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethan-1-one (1.3 equiv), 3-bromothiophene (0.25 mmol), 
Pd(dba)2 (5 mol %), JackiePhos (15 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in CH3OH (1.0 
mL) at 90 ºC. A clear oil (30 mg, 48%) was isolated by flash column chromatography (20:80 to 






1-(2-Benzoylpyrrolidin-1-yl)-2,2,2-trifluoroethan-1-one.  The general procedure for cross-
coupling reactions was employed using 2,2,2-trifluoro-1-(2-(tricyclohexylstannyl)pyrrolidin-1-
yl)ethan-1-one  (1.3 equiv), benzoyl chloride (0.25 mmol), Pd(dba)2 (5 mol %), JackiePhos (15 
mol %), and CuCl (2.0 equiv) in 1,4-dioxane (1.0 mL) at 110 ºC. A pale yellow solid (48 mg, 70%) 
was isolated by flash column chromatography (25:75 ethyl acetate:hexane). 1H NMR (300 MHz, 
CDCl3): δ 7.97 (m, 2H), 7.62 (m, 1H), 7.49 (m, 2H), 5.65 (m, 0.2H), 5.56 (m, 0.8H), 3.87 (m, 2H), 
2.48 (m, 1H), 1.95 (m, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 195.5, 155.5 (m), 134.6, 134.2 
(minor), 133.9 (major), 129.2 (minor, 0.36C), 129.0 (major, 1.64C), 128.7 (major, 1.64C), 128.6 
(minor, 0.36 C), 116.5 (q, J = 285.4 Hz, 1C), 62.7 (major), 62.2 (minor), 48.5 (minor), 47.5 (major), 
31.4 (minor), 28.7 (major), 25.0 (major), 21.0 (minor) ppm. HRMS (ES+): Calcd (M-H)+ 272.0898; 
Found 272.0920. 
 
(S)-1-(2-Benzoylpyrrolidin-1-yl)-2,2,2-trifluoroethan-1-one.  The general procedure for cross-
coupling reactions was employed using (R)-2,2,2-trifluoro-1-(2-(tricyclohexyl-stannyl)pyrrolidin-
1-yl)ethan-1-one (1.3 equiv), benzyol chloride (0.25 mmol), Pd(dba)2 (5 mol %), JackiePhos (15 
mol %), and CuCl (2.0 equiv) in 1,4-dioxane (1.0 mL) at 110 ºC. A pale yellow solid (42 mg, 62%) 
was isolated by flash column chromatography (25:75 ethyl acetate:hexane). The ee value (95.6% 





di-tert-Butyl 2,2'-carbonyl(2S,2'R)-bis(pyrrolidine-1-carboxylate).  The general procedure for 
cross-coupling reactions was employed using (S)-tert-butyl 2-(tricyclohexylstannyl)-pyrrolidine-
1-carboxylate (1.3 equiv), tert-butyl (S)-2-((phenylthio)carbonyl)pyrrolidine-1-carboxylate (0.1 
mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), and CuCl (2.0 equiv) in 1,4-dioxane (0.5 mL) 
at 110 ºC. A white solid (27 mg, 72%) was isolated by column chromatography (30:70 ethyl 
acetate:hexane). The de value (96% de) was determined by GC analysis of the organic layer. 
 
 
di-tert-Butyl 2,2'-carbonyl(2S,2'S)-bis(pyrrolidine-1-carboxylate).  The general procedure for 
cross-coupling reactions was employed using (R)-tert-Butyl-2-(tricyclohexylstannyl)-pyrrolidine-
1-carboxylate (1.3 equiv), tert-butyl (S)-2-((phenylthio)carbonyl)pyrrolidine-1-carboxylate (0.25 
mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), and CuCl (2.0 equiv), in 1,4-dioxane (1.0 mL) 
at 110 ºC. A white solid (88 mg, 92%) was isolated by column chromatography (30:70 ethyl 
acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 4.50 (m, 2H), 3.45 (m, 4H), 2.10 (m, 4H), 1.83 
(m, 4H), 1.42 (s, 18H) ppm. 13C NMR (75 MHz, CDCl3): δ 207.3, 206.3, 154.5, 154.0, 80.0, 79.7, 
79.5, 62.8, 62.5, 61.8, 61.4, 47.1, 46.9, 46.8, 29.7, 29.3, 28.5, 28.2, 28.1, 24.0, 23.9, 23.0, 22.9 





tert-Butyl (R)-2-((S)-2-(6-methoxynaphthalen-2-yl)propanoyl)pyrrolidine-1-carboxylate.  
The general procedure for cross-coupling reactions was employed using (S)-2-
(tricyclohexylstannyl)pyrrolidine-1-carboxylate (1.3 equiv), S-phenyl (S)-2-(6-methoxy-
naphthalen-2-yl)propanethioate (0.1 mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), and CuCl 
(2.0 equiv) in 1,4-dioxane (1 mL) at 110 ºC. A white solid (27 mg, 70%) was isolated by flash 
column chromatography (10:90 to 20:80 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): 7.72 
(m, 3H), 7.33 (m, 1H), 7.26 (m, 2H), 4.46 (m, 1H), 4.25 (m, 0.5H), 4.04 (m, 0.5H), 3.92 (s, 3H), 
3.48 (m, 2H), 1.79 (m, 2H), 1.48 (m, 12H), 1.28 (m, 2H). 13C NMR (75 MHz, CDCl3): 210.4, 
157.9, 154.2, 135.0, 133.9, 129.3, 127.5, 126.7, 119.3, 105.8, 79.9, 64.0, 55.5, 52.1, 47.1, 31.1, 




tert-Butyl (S)-2-((S)-2-(6-methoxynaphthalen-2-yl)propanoyl)pyrrolidine-1-carboxylate.  
The general procedure for cross-coupling reactions was employed using (R)-2-(tricyclohexyl-
stannyl)pyrrolidine-1-carboxylate (1.3 equiv), S-phenyl (S)-2-(6-methoxynaphthalen-2-
yl)propanethioate (0.1 mmol), Pd(dba)2 (5 mol %), JackiePhos (15 mol %), and CuCl (2.0 equiv) 
in 1,4-dioxane (1 mL) at 110 ºC. A colorless liquid (34 mg, 88%) was isolated by flash column 













3H), 7.35 (m, 1H), 7.15 (m, 2H), 4.42 (m, 1H), 4.22 (m, 1H), 3.91(s, 3H), 3.45 (m, 0.7H), 3.20 (m, 
1.0H), 2.83 (0.4H), 2.14 (m, 3H), 1.52 (m, 7H), 1.32 (m, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 
211.4, 210.4, 157.8, 154.3, 135.5, 133.8, 133.6, 126.9, 119.3, 105.7, 80.1, 65.5, 65.3, 55.4, 49.0, 
47.9, 46.8, 30.5, 29.9, 28.7, 28.3, 24.1, 23.3, 18.9 ppm. The de value (97% de) was determined by 
HPLC analysis of the organic layer. 
 





methylpropane-2-sulfinamide.  In a round-bottom flask under argon, a solution of 
tricyclohexyltin chloride (2 mmol, 1.0 equiv), naphthalene (1 mmol, 0.5 equiv) and lithium (20 
mmol, 10 equiv) in anhydrous THF (8 mL) were stirred until the solution turned black. Then the 
solution was stirred for an additional 5 h to generate tricyclohexyltin lithium solution. A solution 
of (R)-N-(3-((tert-butyldimethylsilyl)oxy)propylidene)-2-methylpropane-2-sulfinamide (2.4 
mmol, 1.2 equiv) in THF (5 mL) was placed under Ar and cooled to -78 ºC. After 1 h at -78 ºC, 








































reaction mixture was poured into a separatory funnel containing a mixture of water and diethyl 
ether. The organic layer was separated, washed with brine, dried over Na2SO4, and filtered. Solvent 
was removed under reduced pressure and dried in vacuo to provide the crude product. The crude 
product was purified by flash column chromatography (10% K2CO3/Silica gel, 10:90 ethyl 
acetate:hexane), providing (R)-N-((R)-3-((tert-Butyldimethylsilyl)oxy)-1-(tricyclohexylstannyl)-
propyl)-2-methylpropane-2-sulfinamide as a colorless oil (0.646 g, 49%). 
 
 
(R)-N-((R)-3-Hydroxy-1-(tricyclohexylstannyl)propyl)-2-methylpropane-2-sulfinamide.  To 
a round-bottom flask, (R)-N-((R)-3-((tert-butyldimethylsilyl)oxy)-1-(tricyclohexyl-
stannyl)propyl)-2-methylpropane-2-sulfinamide (0.98 mmol, 1.0 equiv) was added, followed by 
addition of anhydrous THF (2 mL).  The resulting solution was cooled to 0 ºC, tetra-n-
butylammonium fluoride (TBAF, 1.03 mmol, 1.05 equiv) was added, the solution was allowed to 
stir for 1 h at 0 ºC, and finally for 3 h at rt. The reaction was quenched using aqueous sodium 
bicarbonate. The reaction mixture was poured into a separatory funnel containing a mixture of 
water and diethyl ether. The organic layer was separated, washed with brine, dried over Na2SO4, 
and filtered. Solvent was removed under reduced pressure and dried in vacuo to provide the crude 
product. The crude reaction product was purified by flash column chromatography (10% 
K2CO3/Silica gel, 50:50 ethyl acetate:hexane), providing (R)-N-((R)-3-Hydroxy-1-
(tricyclohexylstannyl)propyl)-2-methylpropane-2-sulfinamide as a white solid (0.317 g, 59%). 1H 
NMR (300 MHz, CDCl3): δ 3.88 (m, 1H), 3.79 (m, 1H), 3.66 (b, 2H), 2.30 (m, 1H), 1.87 (m, 7H), 
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1.62 (m, 19H), 1.27 (m, 18H) ppm. 13C NMR (75 MHz, CDCl3): δ 63.3, 56.1, 47.8, 39.3, 32.7, 
29.5, 27.7, 27.3, 23.0 ppm. 
 
 
(R)-3-(((R)-tert-Butylsulfinyl)amino)-3-(tricyclohexylstannyl)propyl methanesulfonate.  
Triethylamine (4.64 mmol, 4 equiv) was added to a solution of (R)-N-((R)-3-hydroxy-1-
(tricyclohexylstannyl)propyl)-2-methylpropane-2-sulfinamide (S3) (1.16 mmol, 1.0 equiv) 
dissolved in anhydrous DCM (6 mL). The mixture was cooled to 0 ºC and mesyl chloride (2.32 
mmol, 2.0 equiv) was then added under Ar. The mixture was stirred overnight, allowing it to warm 
to rt. The reaction was quenched with aqueous sodium bicarbonate. The reaction mixture was 
poured into a separatory funnel containing a mixture of water and diethyl ether. The organic layer 
was separated, washed with brine, dried over Na2SO4, and filtered. Solvent was removed under 
reduced pressure and dried in vacuo to provide the crude product. The crude reaction product was 
purified by flash column chromatography (10% K2CO3/Silica gel, 50:50 ethyl acetate:hexane), 
providing (R)-3-(((R)-tert-Butylsulfinyl)amino)-3-(tricyclohexylstannyl)propyl methanesulfonate 
as a colorless oil (0.615g, 85%). 1H NMR (300 MHz, CDCl3): δ 4.52 (m, 2H), 3.50 (m, 1H), 3.22 
(d, J = 10.4 Hz, 1H), 3.14 (s, 0.8H), 3.09 (s, 2.2 H), 2.31 (m, 1H), 2.11 (m, 1H), 1.87 (m, 7H), 1.65 
(m, 16H), 1.28 (m, 19H) ppm. 13C NMR (75 MHz, CDCl3): δ 69.7, 56.4, 43.5, 37.3, 37.1, 34.0, 










(R)-1-((R)-tert-Butylsulfinyl)-2-(tricyclohexylstannyl)azetidine.  A solution of (R)-3-(((R)-tert-
Butylsulfinyl)amino)-3-(tricyclohexylstannyl)propyl methanesulfonate (0.984 mmol, 1 equiv) in 
anhydrous THF (3 mL) was prepared under Ar and cooled to 0 ºC.  To this mixture, LHMDS (2.95 
mmol, 3.0 equiv, 1M in THF) was added dropwise. The mixture was stirred for 1 h at 0 ºC, and 
then overnight at rt. The reaction was quenched with water. The reaction mixture was poured into 
a separatory funnel containing a mixture of water and diethyl ether. The organic layer was 
separated, washed with brine, dried over Na2SO4, and filtered. Solvent was removed under reduced 
pressure and dried in vacuo to provide the crude product. The crude reaction product was purified 
by flash column chromatography (10% K2CO3/Silica gel, 12:88 ethyl acetate:hexane), providing 
(R)-1-((R)-tert-Butylsulfinyl)-2-(tricyclohexylstannyl)azetidine as a white solid (0.436 g, 84%). 
1H NMR (300 MHz, CDCl3): δ 4.75 (t, J = 9.9 Hz, 1H), 4.58 (m, 1H), 3.40 (m, 1H), 2.62 (m, 1H), 
2.33 (m, 1H), 1.91 (m, 6H), 1.64 (m, 18H), 1.25 (m, 18H) ppm. 13C NMR (75 MHz, CDCl3): δ 
57.1, 56.8, 47.6, 32.6, 29.4, 27.3, 25.1, 23.8 ppm. 
 
 
(R)-1-(tert-Butylsulfonyl)-2-(tricyclohexylstannyl)azetidine.  A solution of (R)-1-((R)-tert-
Butylsulfinyl)-2-(tricyclohexylstannyl)azetidine (0.825 mmol, 1 equiv) in anhydrous DCM (2 mL) 
was cooled to 0 ºC. mCPBA (1.65 mmol, 2 equiv) was added, and the mixture was allowed to 
warm to rt where it was stirred for 1 h.  The reaction was quenched with saturated aqueous 
solutions of sodium bicarbonate (4 mL) and sodium metabisulfite (3 mL). The reaction mixture 
was poured into a separatory funnel containing a mixture of water and diethyl ether. The organic 







under reduced pressure and dried in vacuo to provide the crude product. The crude reaction product 
was purified by flash column chromatography (10% K2CO3/Silica gel, 7:93 ethyl acetate:hexane), 
providing (R)-1-(tert-Butylsulfonyl)-2-(tricyclohexylstannyl)azetidine as a white solid (0.384 g, 
85%). The ee value (99.3% ee) was determined by HPLC analysis of the organic layer. 1H NMR 
(300 MHz, CDCl3): δ 4.84 (quintet, J = 8.5 Hz, 1H), 4.26 (m, 1H), 3.92 (q, J = 7.2 Hz, 1H), 2.44 
(m, 2H), 1.94 (m, 6H), 1.65 (m, 18H), 1.31 (m, 18H) ppm. 13C NMR (75 MHz, CDCl3): δ 59.7, 
55.5, 55.2, 32.7, 29.5, 28.0, 27.4, 24.6, 22.0 ppm. HRMS (ES+): Calcd (M-H)+ 546.2431; Found 
546.2453. 
 
(rac)-1-(tert-Butylsulfonyl)-2-(tricyclohexylstannyl)azetidine. The procedure for (R)-1-(tert-
Butylsulfonyl)-2-(tricyclohexylstannyl)azetidine was employed using (rac)-N-(3-((tert-
butyldimethylsilyl)oxy)propylidene)-2-methylpropane-2-sulfinamide (2.4 mmol) and 
tricyclohexyltin chloride (2 mmol).  A white solid was obtained (217 mg, 20% for 5 steps). 
 
 
1-(tert-Butylsulfonyl)-2-phenylazetidine.  The general procedure for cross-coupling reactions 
was employed using 1-(tert-butylsulfonyl)-2-(tricyclohexylstannyl)azetidine (1.1 equiv), 
bromobenzene (0.1 mmol), Pd(dba)2 (5 mol %), JackiePhos (10 mol %), CuCl (0.5 equiv), and KF 
(2.0 equiv) in toluene (1.0 mL) at 110 ºC. A pale yellow solid (19.5 mg, 77%) was isolated by 
flash column chromatography (5:95 to 10:90 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): 
δ 7.48 (m, 2H), 7.34 (m, 3H), 5.41 (t, J = 8.34 Hz, 1H), 4.31 (q, J = 6.6 Hz, 1H), 3.63 (m, 1H), 
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2.57 (m, 1H), 2.39 (m, 1H), 1.63 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ 141.3, 128.6, 128.5, 
127.7, 65.1, 59.0, 48.4, 24.7, 23.9 ppm. HRMS (ES+): Calcd (M-H)+ 254.1214; Found 254.1226. 
 
(S)-1-(tert-butylsulfonyl)-2-phenylazetidine.  The general procedure for cross-coupling reactions 
was employed using (R)-1-(tert-butylsulfonyl)-2-(tricyclohexyl-stannyl)azetidine (1.1 equiv), 
bromobenzene (0.05 mmol), Pd(dba)2 (5 mol %), JackiePhos (10 mol %), CuCl (0.5 equiv), and 
KF (2.0 equiv) in toluene (0.5 mL) at 110 ºC (74% yield). The ee value (97% ee) was determined 
by HPLC analysis. 
 
 
1-(4-(1-(tert-Butylsulfonyl)azetidin-2-yl)phenyl)ethan-1-one.  The general procedure for cross-
coupling reactions was employed using 1-(tert-butylsulfonyl)-2-(tricyclohexyl-stannyl)azetidine 
(1.1 equiv), 1-(4-iodophenyl)ethanone (0.05 mmol), Pd(dba)2 (5 mol %), JackiePhos (10 mol %), 
CuCl (0.5 equiv), and KF (2.0 equiv) in toluene (0.5 mL) at 110 ºC. A pale yellow solid (8.8 mg, 
60%) was isolated by flash column chromatography (20:80 ethyl acetate:hexane). 1H NMR (300 
MHz, CDCl3): δ 7.95 (d, J = 8.4 Hz, 2H), 7.56 (d, J = 8.3Hz, 2H), 5.46 (t, J = 8.4 Hz, 1H), 4.33 
(q, J = 7.8 Hz, 1H), 3.65 (m, 1H), 2.60 (s, 3H), 2.37 (m, 1H), 1.19 (s, 9H) ppm. 13C NMR (75 MHz, 
CDCl3): δ 197.7, 146.4, 137.2, 128.8, 127.7, 64.2, 59.1, 48.8, 26.8, 24.7, 24.0 ppm. HRMS (ES+): 




(S)-1-(4-(1-(tert-Butylsulfonyl)azetidin-2-yl)phenyl)ethan-1-one.  The general procedure for 
cross-coupling reactions was employed using (R)-1-(tert-butylsulfonyl)-2-
(tricyclohexylstannyl)azetidine (1.1 equiv), 1-(4-bromophenyl)ethanone (0.1 mmol), Pd(dba)2 (5 
mol %), JackiePhos (10 mol %), CuCl (0.5 equiv), and KF (2.0 equiv) in toluene (4.0 mL) at 110 
ºC. A pale yellow solid (21 mg, 72%) was isolated by flash column chromatography (20:80 ethyl 
acetate:hexane). The ee value (97% ee) was determined by HPLC analysis of the organic layer. 
 
 
1-(tert-Butylsulfonyl)-2-(2-(trifluoromethyl)phenyl)azetidine.  The general procedure for 
cross-coupling reactions was employed using 1-(tert-butylsulfonyl)-2-(tricyclohexyl-
stannyl)azetidine (1.1 equiv), 2-(trifluoromethyl)bromobenzene (0.05 mmol), Pd(dba)2 (5 mol %), 
JackiePhos (10 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in toluene (0.5 mL) at 110 ºC. A 
light yellow liquid (9.6 mg, 60%) was isolated by flash column chromatography (20:80 to 30:70 
diethyl ether:hexane). 1H NMR (300 MHz, CDCl3): δ 8.06 (d, J = 7.9 Hz, 1H), 7.62 (m, 2H), 7.38 
(t, J = 7.8 Hz, 1H), 5.87 (t, J = 8.4Hz, 1H), 4.35 (q, J = 8.5 Hz, 1H), 3.69 (m, 1H), 2.69 (m, 1H), 
2.13 (m, 1H), 1.33 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ 140.9, 132.3, 127.7, 126.0, 125.8, 
27.19, 24.38 ppm. HRMS (ES+): Calcd (M-Na)+ 344.0908; Found 344.0903. 
 
(S)-1-(tert-butylsulfonyl)-2-(2-(trifluoromethyl)phenyl)azetidine.  The general procedure for 
cross-coupling reactions was employed using (R)-1-(tert-butylsulfonyl)-2-
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(tricyclohexylstannyl)azetidine (1.1 equiv), 2-(trifluoromethyl)bromobenzene (0.1 mmol), 
Pd(dba)2 (5 mol %), JackiePhos (10 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in toluene (4.0 
mL) at 110 ºC. A light yellow liquid (23 mg, 78%) was isolated by flash column chromatography 
(20:80 to 30:70 diethyl ether: hexane). The ee value (92% ee) was determined by chiral GC 
analysis of the organic layer. 
 
 
Ethyl 4-(1-(tert-butylsulfonyl)azetidin-2-yl)benzoate.  The general procedure for cross-coupling 
reactions was employed using 1-(tert-butylsulfonyl)-2-(tricyclohexylstannyl)azetidine (1.1 equiv), 
ethyl 4-bromobenzoate (0.1 mmol), Pd(dba)2 (5 mol %), JackiePhos (10 mol %), CuCl (0.5 equiv), 
and KF (2.0 equiv) in toluene (1.0 mL) at 110 ºC. A pale yellow solid (25 mg, 78%) was isolated 
by flash column chromatography (15:85 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 
8.04 (d, J = 8.5 Hz, 2H), 7.54 (d, J = 8.5Hz, 2H), 5.46 (t, J = 8.5 Hz, 1H), 4.35 (m, 3H), 3.65 (m, 
1H), 2.57 (m, 1H), 2.38 (m, 1H), 1.39 (t, J = 7.1Hz, 3H), 1.18 (s, 9H) ppm. 13C NMR (75 MHz, 
CDCl3): δ 166.5, 146.1, 130.6, 130.0, 127.5, 64.3, 61.2, 59.1, 24.7, 24.0, 14.5 ppm. HRMS (ES+): 
Calcd (M-H)+ 326.1426; Found 326.1425. 
 
Ethyl (S)-4-(1-(tert-butylsulfonyl)azetidin-2-yl)benzoate.  The general procedure for cross-
coupling reactions was employed using (R)-1-(tert-butylsulfonyl)-2-(tricyclohexyl-
stannyl)azetidine (1.1 equiv), 4-bromobenzoate (0.1 mmol), Pd(dba)2 (5 mol %), JackiePhos (10 
mol %), CuCl (0.5 equiv), and KF (2.0 equiv) in toluene (1.0 mL) at 110 ºC. A pale yellow solid 
	  
	  140	  
(23 mg, 72%) was isolated by flash column chromatography (15:85 ethyl acetate:hexane). The ee 
value (98.6% ee) was determined by HPLC analysis of the organic layer. 
 
 
3-(1-(tert-Butylsulfonyl)azetidin-2-yl)benzaldehyde.  The general procedure for cross-coupling 
reactions was employed using 1-(tert-butylsulfonyl)-2-(tricyclohexylstannyl)azetidine (1.1 equiv), 
3-bromobenzaldehyde (0.05 mmol), Pd(dba)2 (5 mol %), JackiePhos (10 mol %), CuCl (2.0 equiv), 
and KF (2.0 equiv) in toluene (0.5 mL) at 110 ºC. A pale yellow solid (8.7 mg, 62%) was isolated 
by flash column chromatography (20:80 ethyl acetate:hexane). 1H NMR (300 MHz, CDCl3): δ 
10.03 (s, 1H), 8.03 (t, J = 1.6, 1H), 7.82 (dt, J = 7.6, 1.7, 1H), 7.73 (dt, J = 7.7, 1.4, 1H), 7.54 (t, J 
= 7.6, 1H), 5.50 (t, J = 8.4, 1H), 4.33 (q, J = 7.7, 1H), 3.67 (m, 1H), 2.58 (m, 1H), 2.40 (m, 1H), 
1.19 (s, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ 192.2, 142.5, 136.9, 133.8, 130.0, 129.4, 128.3, 
64.0, 59.2, 48.8, 24.6, 24.0 ppm. HRMS (ES+): Calcd (M-Na)+ 304.0983; Found 304.1010. 
 
(S)-3-(1-(tert-Butylsulfonyl)azetidin-2-yl)benzaldehyde.  The general procedure for cross-
coupling reactions was employed using (R)-1-(tert-butylsulfonyl)-2-(tricyclohexyl-
stannyl)azetidine (1.1 equiv), 3-bromobenzaldehyde (0.1 mmol), Pd(dba)2 (5 mol %), JackiePhos 
(10 mol %), CuCl (2.0 equiv), and KF (2.0 equiv) in toluene (4.0 mL) at 110 ºC. A pale yellow 
solid (14.5 mg, 51%) was isolated by flash column chromatography (20:80 ethyl acetate:hexane). 





1-(tert-Butylsulfonyl)-2-(thiophen-3-yl)azetidine.  The general procedure for cross-coupling 
reactions was employed using 1-(tert-butylsulfonyl)-2-(tricyclohexylstannyl)azetidine (1.1 equiv), 
3-bromothiophene (0.1 mmol), Pd(dba)2 (5 mol %), JackiePhos (10 mol %), CuCl (0.5 equiv), and 
KF (2.0 equiv) in toluene (1.0 mL) at 110 ºC. A pale yellow solid (14 mg, 54%) was isolated by 
flash column chromatography (20:80 diethyl ether:hexane). 1H NMR (300 MHz, CDCl3): δ 7.29 
(m, 3H), 5.50 (t, J = 8.4 Hz, 1H), 4.28 (q, J = 7.7 Hz, 1H), 3.59 (m, 1H), 2.56 (m, 2H), 1.12 (s, 9H) 
ppm. 13C NMR (75 MHz, CDCl3): δ 142.8, 126.7, 126.4, 123.8, 60.3, 59.1, 48.2, 24.0, 23.8 ppm. 
HRMS (ES+): Calcd (M-H)+ 260.0778; Found 260.0728. 
 
(S)-1-(tert-butylsulfonyl)-2-(thiophen-3-yl)azetidine.  The general procedure for cross-coupling 
reactions was employed using (R)-1-(tert-butylsulfonyl)-2-(tricyclohexyl-stannyl)azetidine (1.1 
equiv), 3-bromothiophene (0.1 mmol), Pd(dba)2 (5 mol %), JackiePhos (10 mol %), CuCl (0.5 
equiv), and KF (2.0 equiv) in toluene (4.0 mL) at 110 ºC. A pale yellow solid (9.5 mg, 37%) was 
isolated by flash column chromatography (20:80 diethyl ether:hexane). The ee value (89% ee) was 
determined by chiral GC analysis. 
 
Preparation of (R)-2,2,2-Trifluoro-1-(2-(tricyclohexylstannyl)pyrrolidin-1-yl)ethanone using 






(R)-N-((R)-4-Chloro-1-(tricyclohexylstannyl)butyl)-2-methylpropane-2-sulfinamide.  In a 
round-bottom flask under argon, a solution of tricyclohexyltin chloride (2.2 mmol, 1.0 equiv), 
naphthalene (1.1 mmol, 0.5 equiv) and lithium (22 mmol, 10 equiv) in anhydrous THF (8 mL) 
were stirred until the solution turned black. Then the solution was stirred for an additional 5 h to 
generate tricyclohexyltin lithium solution. To a solution of (R)-N-(4-chlorobutylidene)-2-
methylpropane-2-sulfinamide (2.86 mmol, 1.3 equiv) in THF (6 mL) which was under Ar and 
cooled to -78 ºC, the tricyclohexyltin lithium solution was added. The mixture was allowed to stir 
at -78 ºC for 1 h. The solution was quenched with methanol followed by water at -78 ºC. The 
reaction mixture was poured into a separatory funnel containing a mixture of water and diethyl 
ether. The organic layer was separated, washed with brine, dried over Na2SO4, and filtered. Solvent 
was removed under reduced pressure and dried in vacuo to provide the crude product. The crude 
reaction products were purified by flash column chromatography (10% K2CO3/Silica gel, 5:95 to 
10:90 ethyl acetate:hexane), providing (R)-N-((R)-4-Chloro-1-(tricyclohexylstannyl)butyl)-2-































2H), 3.45 (m, 1H), 2.23 (d, J = 10.6 Hz, 1H), 1.68 (m, 29H), 1.23 (m, 17H) ppm. 13C NMR (75 
MHz, CDCl3): δ 55.8, 48.6, 44.8, 36.9, 32.4, 29.3, 27.7, 27.1, 25.6, 22.6 ppm. 
 
 
(R)-1-((R)-tert-Butylsulfinyl)-2-(tricyclohexylstannyl)pyrrolidine.  A solution of (R)-N-((R)-4-
Chloro-1-(tricyclohexylstannyl)butyl)-2-methylpropane-2-sulfinamide (428 mg, 0.74 mmol) in 
anhydrous THF (1 mL) was prepared under Ar and cooled to 0 ºC.  To this mixture, LHMDS (2.22 
mmol, 3.0 equiv, 1M in THF) was added dropwise. The mixture was stirred for 1 h at 0 ºC, and 
then overnight at rt. The reaction was quenched with water. The reaction mixture was poured into 
a separatory funnel containing a mixture of water and diethyl ether. The organic layer was 
separated, washed with brine, dried over Na2SO4, and filtered. The reaction mixture was poured 
into a separatory funnel containing a mixture of water and diethyl ether. The organic layer was 
separated, washed with brine, dried over Na2SO4, and filtered. Solvent was removed under reduced 
pressure and dried in vacuo to provide the crude product. The crude reaction products were purified 
by flash column chromatography (10% K2CO3/Silica gel, 15:85 to 20:80 ethyl acetate:hexane), 
providing (R)-1-((R)-tert-Butylsulfinyl)-2-(tricyclohexylstannyl)pyrrolidine (0.272 g, 68%). 1H 
NMR (300 MHz, CDCl3): δ 3.86 (m, 1H), 3.59 (m, 1H), 3.27 (m, 1H), 2.23 (m, 1H), 1.92 (m, 9H), 
1.67 (m, 17H), 1.28 (m, 19H) ppm. 13C NMR (75 MHz, CDCl3): δ 57.6, 56.0, 41.8, 32.6, 31.1, 
29.6, 29.0, 27.9, 27.3, 26.9, 25.5, 24.5 ppm. (1-tert-butylsulfonylpyrrolidin-2-yl)-tricyclohexyl-
stannane was prepared using (R)-1-((R)-tert-Butylsulfinyl)-2-(tricyclohexylstannyl)pyrrolidine 
(1.0 equiv) and mCPBA (1.5 equiv) in anhydrous DCM). 1H NMR (300 MHz, CDCl3): δ 3.86 (m, 






butylsulfinyl)-2-(tricyclohexylstannyl)pyrrolidine (0.16 mmol, 1 equiv) and anhydrous ZnCl2 
(0.064 mmol, 0.4 equiv) were added to a round-bottom flask.  After the flask was evacuated and 
backfilled with argon, anhydrous DCM (1 mL) was added. Thiophenol (0.48 mmol, 3 equiv) was 
then added to the solution at rt. After the solution was stirred for 24 h, it was quenched by NaOH 
(2 mL, 2M, aq.) and extracted by diether ether (1 mL). The organic layer was dried over Na2SO4 
and solvent was removed under reduced pressure to get the crude product, (R)-2-
(tricyclohexylstannyl)pyrrolidine. To the crude product, triethylamine (0.8 mmol, 5.0 equiv) and 
anhydrous DCM (1 mL) were added. The reaction mixture was cooled to 0 ºC, and trifluoroacetic 
anhydride (TFAA, 0.64 mmol, 4 equiv) was added. The reaction mixture was stirred for 10 min at 
0 ºC, and then overnight at rt. The reaction mixture was poured into a separatory funnel containing 
a mixture of water and DCM. The organic layer was separated, washed with brine, dried over 
Na2SO4, and filtered. Solvent was removed under reduced pressure and dried in vacuo to provide 
the crude product. The crude reaction products were purified by flash column chromatography (10% 
K2CO3/Silica gel, 5:95 ethyl acetate:hexane), providing (R)-2,2,2-Trifluoro-1-(2-
(tricyclohexylstannyl)pyrrolidin-1-yl)ethanone as a white solid (14.6 mg, 18% for 2 steps). The ee 
value (98% ee) was determined by chiral HPLC analysis. The (R)-enantiomer was generated, 
which is consistent with the anticipated stereoinduction from the (R)-enantiomer of Ellman’s 




3.6.4 Mechanistic investigations 
Investigation of stereochemistry of transmetallation. 
  
 
An aqueous solution of (S)-2-phenylpyrrolidine hydrochloride (15.5 mg, 0.08 mmol) and NaHCO3 
(0.32 mmol, 4 equiv) was stirred for 4 h at rt. The reaction mixture was extracted with diethyl ether 
(1 mL x 3). The combined organic layers were washed with brine (10 mL), and dried over Na2SO4. 
The organic layer was filtered, and concentrated under reduced pressure providing free base (S)-
2-phenylpyrrolidine. To the flask containing (S)-2-phenylpyrrolidine, dry DCM (1 mL) and 
triethylamine (0.24 mmol, 3 equiv) were added. The reaction flask was cooled to 0 ºC, and TFAA 
(0.16 mmol, 2 equiv) was added dropwise. The reaction mixture was allowed to warm to rt and 
stirred overnight. The reaction mixture a was washed with water, and chiral GC was used to 
analyze the organic layer. Compound b was also prepared using the general procedure for cross-







































Condition and results: 
Column IC3 
Mobile Phase 100 : 0.1= (5%CH3CN/CH3OH) : H2O 








(R)-2-methyl-N-(1-(tricyclohexylstannyl)ethyl)propane-2-sulfonamide was prepared from 
(R)-N-ethylidene-2-methylpropane-2-sulfinamide. In a round-bottom flask under argon, a solution 
of tricyclohexyltin chloride (2 mmol, 1.0 equiv), naphthalene (1.0 mmol, 0.5 equiv) and lithium 
(20 mmol, 10 equiv) in anhydrous THF (8 mL) were stirred until the solution turned black. Then 
the solution was stirred for an additional 5 h to generate tricyclohexyltin lithium solution. To a 
solution of (R)-N-ethylidene-2-methylpropane-2-sulfinamide (2.6 mmol, 1.3 equiv) in THF (6 mL) 
which was under Ar and cooled to -78 ºC, tricyclohexyltin lithium solution (2 mmol, 1.0 equiv) 
was added. The mixture was allowed to stir at -78 ºC for 1 h. The solution was quenched with 
methanol followed by water at -78 ºC. The reaction mixture was poured into a separatory funnel 
containing a mixture of water and diethyl ether. The organic layer was separated, washed with 
brine, dried over Na2SO4, and filtered. Solvent was removed under reduced pressure and dried in 
vacuo to provide the crude product, (R)-2-methyl-N-((R)-1-(tricyclohexylstannyl)ethyl)propane-
2-sulfinamide. mCPBA (4 mmol, 2 equiv) was added to (R)-2-methyl-N-((R)-1-(tricyclohexyl-

















was stirred for 1 h at rt. The reaction was quenched with saturated aqueous solutions of sodium 
bicarbonate (4 mL) and sodium metabisulfite (3 mL). The reaction mixture was poured into a 
separatory funnel containing a mixture of water and diethyl ether. The organic layer was separated, 
washed with brine, dried over Na2SO4, and filtered. Solvent was removed under reduced pressure 
and dried in vacuo to provide the crude product. The crude reaction products were purified by flash 
column chromatography (10% K2CO3/Silica gel, 4:96 to 6:94 ethyl acetate:hexane), providing (R)-
2-methyl-N-(1-(tricyclohexylstannyl)ethyl)propane-2-sulfonamide as a white solid (0.605 g, 57% 
for 2 steps). 1H NMR (300 MHz, CDCl3): δ 3.68 (d, J = 10.2 Hz, 1H), 3.52 (m, 1H), 1.90 (m, 6H), 
1.62 (m, 21H), 1.39 (s, 9H) 1.7 (m, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ 59.6, 39.6, 32.6, 29.4, 
27.5, 27.2, 24.6, 24.4 ppm. HRMS (ES+): Calcd (M-H)+ 534.2431; Found 534.2438. The ee value 
(99.8 % ee) was determined by HPLC analysis. The crystal of (R)-2-methyl-N-(1-
(tricyclohexylstannyl)ethyl)propane-2-sulfonamide was grown from diethyl ether by slow 
evaporation. 
 
3.6.5 Single crystal X-ray structure determination 
Experimental Description  
Geometry and intensity data collection with a Bruker SMART APEXII CCD area detector on a 
D8 goniometer at 100 K. The temperature during the data collection was controlled with an Oxford 
Cryosystems Series 700+ instrument. Preliminary lattice parameters and orientation matrices were 
obtained from three sets of frames. Data were collected using graphite-monochromated and 0.5 
mm-MonoCap-collimated Mo-Kα radiation (λ = 0.71073 Å) with the ω scan method. Data were 
processed with the INTEGRATE program of the APEX2 software for reduction and cell 
refinement. Multi-scan absorption corrections were applied by using the SCALE program for the 
	  
	  150	  
area detector. The structure was solved by the direct method and refined on F2 (SHELXTL). Non-
hydrogen atoms were refined with anisotropic displacement parameters, and hydrogen atoms on 
carbons were placed in idealized positions (C-H = 0.95-1.00 Å) and included as riding with Uiso(H) 
= 1.2 or 1.5 Ueq(non-H), and the hydrogen atom on the nitrogen atom was refined with a restrained 
distance of N-H 0.86 Å. 
 



















Conditions and results: 
Column IC3 
Mobile Phase 85 : 15 = (5%CH3CN/CH3OH) : H2O 

















Conditions and results: 
Column IA 
Mobile Phase 75 : 25 = (5% CH3CN/CH3OH) : H2O 
Flow 0.8 mL/min 




























Conditions and results: 
Column IA 
Mobile Phase 50 : 50 = (5% CH3CN/CH3OH) : H2O 
Flow 1.0 mL/min 
















Conditions and results: 
Column IA 
Mobile Phase 25 : 75 = ( CH3CN : H2O) for 15 min, gradually to 40: 60 ( CH3CN : 
H2O) at 40 min. 
Flow 1.2 mL/min 
















Conditions and results: 
Column IA 
Mobile Phase 65 : 35 = (5% CH3CN/CH3OH) : H2O 
Flow 1.0 mL/min 






























Conditions and results: 
Column ODRH 
Mobile Phase 75 : 25 = (5% CH3CN/CH3OH) : H2O 
Flow 0.6 mL/min 









Conditions and results: 
Column IC3 
Mobile Phase 90 : 10 = (5% CH3CN/CH3OH) : H2O 
Flow 0.5 mL/min 
















Conditions and results: 
Column IA 
Mobile Phase 75 : 25 = (5% CH3CN/CH3OH) : H2O 
Flow 0.6 mL/min 
















Conditions and results: 
Column IA 
Mobile Phase 85 : 15 = (5% CH3CN/CH3OH) : H2O 
Flow 0.8 mL/min 
















Conditions and results: 
Column IA 
Mobile Phase 85 : 15 = (5% CH3CN/CH3OH) : H2O 
Flow 0.8 mL/min 














Conditions and results: 
Column IC3 
Mobile Phase 90 : 10 = (5% CH3CN/CH3OH) : H2O 
Flow 0.5 mL/min 
















Conditions and results: 
Column IC3 
Mobile Phase 90 : 10 = (5% CH3CN/CH3OH) : H2O 
Flow 0.6 mL/min 
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